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CD: Cluster of differentiation

CFU: Colony forming unit
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YPDps: YPD+10% Penicillin/Streptomycin 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Summary in French: !
Cryptococcus neoformans (C. neoformans) est une levure opportuniste basidiomycète 
cosmopolite de l’environnement. Ce champignon a la particularité de survivre à la pha-
gocytose de nombreux organismes allant des protozoaires unicellulaires aux cellules 
immunitaires spécialisées des mammifères (macrophages, cellules dendritiques, neu-
trophiles). Il s’agit d’un microorganisme intracellulaire facultatif, ce qui lui confère no-
tamment la possibilité d’échapper au système immunitaire et d’utiliser les cellules 
hôtes comme véhicules (stratégie du cheval de Troie) pour franchir les barrière épithé-
liales de l’organisme.

Cette levure est responsable de la cryptococcose qui est une infection opportuniste 
survenant le plus souvent à un stade avancé du déficit immunitaire lors de l’infection 
par le VIH ou à l’occasion d’autres déficits immunitaires cellulaires (greffe d’organe so-
lide, déficit lymphoïde chronique, corticothérapie au long cours, …). 

Les isolats responsables de la cryptococcose chez l’homme sont divers en terme de 
sérotypes, de mating-type et de ploïdie. Les différentes espèces/variétés capables de 
provoquer la cryptococcose sont C. neoformans var. grubii (sérotype A), C. neoformans 
var. neoformans (sérotype D) et Cryptococcus gattii (sérotype B et C) [1]. Cryptococcus 
neoformans se multiplie par bourgeonnement (mode asexué) mais est également ca-
pable d’une reproduction sexuée impliquant des mating-types de signes opposés 
(MATa et MATalpha) mais également de même signe sexuel qui contribue de façon im-
portante à la variabilité des populations même si la reproduction asexuée est le mode 
d’expansion principal [1]. Une variabilité de ploïdie existe également chez cette levure 
majoritairement haploïde, avec la possibilité d’aneuploïdie, de diploïdisation. Au final, 
les isolats cliniques à l’échelle mondiale sont majoritairement des souches de C. neo-
formans var. grubii, MATalpha et haploïde. 

Le Center for Diseases Control (CDC, Atlanta, USA) a récemment estimé à 1 million/an 
le nombre de cas de cryptococcose neuro-méningée et 700 000 décès associés, ce 
qui fait de cette entité une pathologie aussi préoccupante que la tuberculose en 
termes de santé publique mondiale [2]. La cryptococcose est une infection le plus 
souvent disséminée, au cours de laquelle la localisation méningo-encéphalique est la 
plus fréquente et la plus grave. La méningo-encéphalite est toujours mortelle en 
l’absence de traitement, et reste fatale dans environ 20% des cas malgré un traitement 
antifongique [3]. L’atteinte pulmonaire est la deuxième localisation viscérale. Chez 
l’homme, l’infection commence par l’inhalation de particules infectantes que l’on sup-
pose être des basidiospores ou des levures desséchées présentes dans le milieu exté-
rieur. La primo-infection a lieu dans l’enfance et passe le  plus souvent inaperçue ou 
sous la forme d’une pneumonie non étiquetée. Le système immunitaire est habituelle-
ment efficace pour contrôler la maladie mais des levures persisteraient ensuite dans 
l’organisme dans les macrophages alvéolaires et/ou dans un granulome tissulaire pul-
monaire pendant une phase dite de latence. A ce stade, on suppose que les levures 
sont dormantes. La notion de dormance a été démontrée épidémiologiquement [4] 
mais aucune preuve biologique n’existe à ce jour. L'infection survient si, à la faveur 
d’une immunodépression (principalement cellulaire), les levures se réactivent, pour en-
suite se multiplier puis disséminer via la circulation sanguine dans l’organisme [5]. La 
traversée de la barrière hémato-encéphalique va alors conduire à une méningo-encé-
phalite qui est la présentation clinique la plus commune et la plus grave. 

D’un point de vue général, on sait que les déterminants des maladies infectieuses dé-
pendent de facteurs d’hôtes et de facteurs spécifique au pathogène. Certains facteurs 
 6
!                                                                                                                                                
de virulence ont déjà été bien identifiés dans des modèles expérimentaux murins mais 
aussi chez l’homme et in vitro au cours de l’interaction avec les macrophages.

Bien que la diversité des isolats de C. neoformans soit relativement bien établie en 
terme de génotypes [6], la diversité de l’adaptation de la levure à divers environne-
ments n’est que partiellement connue. En particulier, il n’est toujours pas définitive-
ment établi comment la variabilité d’évolution de la maladie chez l’homme pourrait être 
reliée au statut immunitaire ou au patrimoine génétique du patient, à des facteurs fon-
giques ou à leur combinaison. Ces facteurs fongiques sont d'ailleurs habituellement 
étudiés à partir de souches de référence et des mutants qui en sont générés mais ra-
rement à partir de souches cliniques. Récemment, il a été montré pour C. gattii, qu’un 
génotype spécifique (VGII, responsable d’une épidémie sur l’Ile de Vancouver en Co-
lombie Britannique, Canada) était associé à un phénotype particulier avec une aug-
mentation de la capacité de prolifération intracellulaire des levures in vitro mais égale-
ment un plus grande virulence chez la souris [7]. Pour C. neoformans, l’influence d’un 
génotype ou d’un phénotype particulier sur l’évolution de la maladie n’a pas encore été 
mise en évidence.
!
L’objectif de mon travail était de comprendre comment la diversité des isolats cliniques 
de C. neoformans pourrait influencer l’évolution et les caractéristiques de l’infection. 
Pour répondre à cette question, nous avons exploité (i) les souches et les données cli-
niques collectées au cours de l’étude CryptoA/D (étude clinique multicentrique coor-
donnée dans le laboratoire) (ii) un modèle de cryptococcose disséminée murine clini-
quement pertinent (iii) un modèle d’interaction avec le macrophage in vitro et nous 
avons mis au point de nombreux outils permettant une quantification précise de diffé-
rents paramètres. Nous nous sommes ensuite orientés vers l’étude de l’adaptation de 
C. neoformans dans ces mêmes modèles expérimentaux.
!
Dans un premier temps nous avons mis au point un modèle d’interaction entre les le-
vures et les macrophages en utilisant la lignée cellulaire J774 de macrophage murin et 
la souche de référence de C. neoformans H99. Nous nous sommes particulièrement 
intéressés à l’indice de phagocytose (nombre de levures internalisées pour 100 macro-
phages) et la prolifération intracellulaire des levures (taux de levures générées après 
une durée d’incubation définie). Pour cela, nous avons mis au point des méthodes ba-
sées sur des marqueurs fluorescence [anticorps anti-capsule couplés à des anticorps 
secondaires fluorescents et un marqueur fluorescent spécifique de la chitine (Calco-
fluor)] et avons quantifié ces paramètres en cytométrie de flux quantitative (MacsQuant 
analyser). Le calcofluor permet de marquer en fluorescence (bleu) la paroi des levures 
(cellules mères) qui en se multipliant vont transmettre une partie de leur fluorescence à 
la paroi des levures filles. Les levures filles vont donc être marquées plus faiblement 
que les levures mères. Il est ainsi aisé de différencier les levures mères et filles et de 
calculer la prolifération des levures en cytométrie de flux. Nous avons ensuite validé le 
modèle et les outils à l’aide de mutants (KO) de différents gènes de virulence bien ca-
ractérisés, générés dans le fond génétique de la souche de référence H99 [lac1∆ (KO 
pour la laccase 1, Lac1), vps34∆ (KO pour la PI3 kinase, Vps34), vad1∆ (KO pour la 
DEAD-box RNA helicase, Vad1) and app1∆ (KO pour l’antiphagocytic protein, App1), 
ipc1∆ (pour lequel l’inositol-phosphoryl ceramide synthase, Ipc1, est sous-exprimée)] 
et dont le phénotype d’interaction avec le macrophage était bien connu.

Après ces mises au point, nous avons criblé 54 souches cliniques C. neoformans var. 
grubii MATalpha haploïdes isolées de liquides céphalorachidiens de 54 patients immu-
nodéprimés (VIH et non-VIH) et comparé les données à celles obtenues avec la souche 
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de référence H99 dans les mêmes conditions. Les 54 souches ont été sélectionnées 
dans la collection issue de l’étude CryptoA/D et nous disposions donc des données 
cliniques associées. 

Nous avons pu montrer que les souches cliniques étaient diverses intrinsèquement en 
terme de production de mélanine, d’uréase, et de capacité de multiplication (courbes 
de croissance). Il existait également une diversité importante de leur interaction avec 
les cellules J774 mesurée par l’indice de phagocytose (PI, variation de 30 fois), et les 
indices de prolifération intracellulaire à 2 heures (IPH2, 50 fois) et à 48 heures (IPH48, 
16 fois). Grâce aux données cliniques associées à ces souches, nous avons pu mettre 
en évidence que deux phénotypes particuliers étaient associés à des évolutions cli-
niques défavorables. Les souches fortement phagocytées (ratio ≥ 0,5 par rapport à 
H99) et qui avaient un indice de prolifération important à 2 heures  (ratio > 1 par rap-
port à H99) avaient été isolées de patients pour lesquels l'évolution avait été plus 
souvent fatale (p=0.05) et les souches peu phagocytées (ratio < 0.5) et avec un indice 
de prolifération faible (ratio ≤ 1) avaient été plus souvent isolées de patients en échec 
du traitement d’induction (15 jours de bithérapie antifongique). Sur les 54 souches cli-
niques initiales, nous avons ensuite sélectionné 9 souches cliniques aux phénotypes 
extrêmes et variables et avons approfondi l’étude de leur virulence à l’aide du modèle 
murin d’infection et en analysant l’expression de différents gènes de virulence dans le 
modèle d’interaction avec le macrophage. La virulence de ces isolats était variable, 
certains isolats étant plus (AD2-82a) et d’autres moins virulents (AD1-07a, AD1-95a) 
que H99. D’autre part, il existait également une corrélation inverse entre l’expression 
du gène APP1 de la levure (connu pour son action anti-phagocytaire) et l’indice de 
phagocytose des souches cliniques, et une corrélation entre expression des gènes de 
virulence IPC1, VAD1, APP1, COX1 (PCR quantitative en temps réel), et la prolifération 
intracellulaire à 48H des souches cliniques.

Ces résultats suggèrent fortement que les souches cliniques sont différentes intrinsè-
quement en terme de phénotype d’interaction avec les macrophages, ce qui avait été 
montré avec quelques souches et des polynucléaires neutrophiles humains [8], et que 
ce phénotype pourrait influencer l’évolution de la maladie et la réponse au traitement 
chez l’homme, ce qui en revanche n'avait jamais été démontré. Les souches de phé-
notype "forte phagocytose/forte prolifération" pourraient être responsable de la plus 
grande mortalité en raison des dégâts qu’elles pourraient causer aux macrophages 
sensés contrôler la maladie après phagocytose, aboutissant à leur lyse et au relargage 
ultérieur de nombreuses levures dans le milieu extérieur. Par ailleurs, les cellules de 
phénotype "faible phagocytose/faible prolifération" pourraient être plus résistantes au 
traitement d’induction en raison de leur faible prolifération ou d’un potentiel état "dor-
mant". L'hypothèse que nous soulevons ici provient des données générées au cours 
de l’interaction avec le macrophage. En effet, après 48 heures d’interaction avec le 
macrophage, il persiste une population de levures mères (environ 30%), donc suppo-
sée ne pas s’être divisée, alors qu’en condition de croissance maximale in vitro, cette 
proportion est très faible. La proportion de ces cellules supposées dormantes est éga-
lement variable d’une souche à l’autre. 
!
Pour mettre en évidence ce phénomène de dormance, nous avons mis en place de 
nombreux autres outils basés sur une analyse morphologique et en cytométrie de flux 
en nous focalisant sur les modèles de cryptococcose murine et d’interaction avec le 
macrophage. Nous avons utilisé le calcofluor pour suivre la prolifération des levures in 
vivo et dans les macrophage associé à un marqueur de viabilité des levures (TOPRO) 
et un marqueur de stress intracellulaire (CMFDA [9], associé au taux de glutathion in-
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tracellulaire) après avoir testé ces marqueurs dans différentes conditions de stress (in-
cubation dans l’eau, dans l’eau oxygénée, dans le milieu de culture cellulaire). Nous 
avons ensuite étudié l’évolution de ces marqueurs au cours de l’infection dans les 
poumons des souris et au cours de l’interaction avec les macrophages. Il est apparu 
qu’au cours des premières heures après infection ou internalisation dans les macro-
phages, la fluorescence CMFDA augmentait dans les levures suggérant une bonne 
adaptation au stress, mais après quelques heures d’incubation supplémentaires, une 
population de cellules avec une faible fluorescence CMFDA apparaissait. Ce phéno-
mène concernait un faible nombre de cellules et d’abord les levures mères puis les le-
vures filles.

Ainsi, pour explorer cette population faiblement marquée au CMFDA et minoritaire, 
nous avons du infecter un nombre important de souris. Nous avons ensuite analysé les 
levures issues du broyat de tous ces poumons à l’aide d’une machine appelée Images-
treamX, permettant d’analyser la morphologie (photos de chaque évènement) de 10 
000 cellules dans plusieurs canaux de fluorescence en flux et de mettre ainsi en paral-
lèle l’intensité de la fluorescence avec la morphologie de la cellule. Cet outil nous est 
apparu comme essentiel pour détecter les artéfacts de fluorescence et les éliminer, et 
ainsi interpréter correctement les données générées par l'analyse des levures extraites 
des broyats de poumons. Sept jours après infection dans les poumons des souris et 
24 heures après l’interaction avec les macrophages, nous avons constaté la présence 
de populations ayant respectivement une fluorescence élevée, modérée ou faible au 
CFMDA. La répartition des différentes populations était variable en fonction de la 
souche étudiée (souches cliniques AD1-07a, AD1-83a) en comparaison à la souche de 
référence H99. En analysant plus finement la population ayant une fluorescence CMF-
DA élevée, nous avons ainsi pu constater qu’une grande proportion de cette popula-
tion correspondait à des levures mortes. Ceci a été possible grâce à l’utilisation de dif-
férents marqueurs cellulaires permettant l’analyse de la quantification des ARN totaux, 
de l’activité mitochondriale, et de la morphologie des membranes plasmiques et du 
noyau. Ensuite, nous avons pu mettre en évidence à l’aide des algorithmes d’analyse 
d’image disponibles dans le logiciel ImagestreamX, qu’une population de levures fai-
blement fluorescentes en CMFDA avait une morphologie particulière par rapport aux 
autres populations.

Nous avons ensuite entrepris de trier les levures issues des poumons et après interac-
tion avec le macrophage pour analyser les capacités de croissance et l’expression de 
certains gènes de ces différentes populations en comparaison aux levures en fin de 
croissance in vitro (phase stationnaire). Nous avons pu montrer que les levures faible-
ment fluorescente au CMFDA issues des poumons de souris avaient une capacité de 
croissance inférieure à celle des autres populations et étaient dépendantes de la pré-
sence de sérum de veau fœtal pour stimuler leur croissance. Après analyse (single-cell 
PCR quantitative en temps réel) l’expression de différents gènes impliqués dans les 
phénomènes de résistance à la restriction en nutriment, d’entrée en phase stationnaire, 
d’autophagie ou de la synthèse de la paroi ou de la capsule, nous avons pu montrer 
que les populations de cellules faiblement fluorescente au CMFDA (provenant de pou-
mons de souris ou de macrophages) sur-exprimaient un gène mitochondrial (COX1) et 
d’autophagie (ATG9) et sous-exprimait les gènes impliquées dans la néoglucogenèse 
(PCK1) à l’inverse des autres populations.

Ainsi, grâce à la mise en place de nouveaux outils, nous avons des arguments pour 
penser que la population de levures faiblement fluorescente au CMFDA pourrait être 
une population composée de levures dormantes. Le gène mitochondrial COX1 et les 
protéines associées à l’activité respiratoire sont connues pour être sur-exprimées en 
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réponse à l’hypoxie à l’inverse de ce qui se peut se passer avec Saccharomyces cere-
visiae, Schizosaccharomyces pombe ou Candida albicans [10]. Pour valider ce phéno-
mène, il est maintenant indispensable de pourvoir générer un grand nombre de levures 
ayant ce phénotype dans des conditions standardisées. Nous sommes actuellement 
en train de tester différents milieux et conditions de culture pour répondre à ce besoin. 
Si ces expériences se concrétisent, nous aurions le moyen d’étudier la biologie de la 
dormance chez C. neoformans, et ainsi les moyens d’éradiquer ces levures dormantes 
chez les patients immunodéprimés à risque de cryptococcose.
!
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Cryptococcus neoformans (C. neoformans) is basidiomycetous opportunistic yeast that is 
widely present in the environment. This fungus can survive the predation of various 
organisms ranging from protozoans to metazoans through ready-made virulence traits [1]. 
Cryptococcus neoformans interacts closely with uni- or multicellular organisms that are 
natural predators in nature (amoeba, paramecium, nematodes) [2-4] and with cells 
dedicated to innate immune response of metazoans (macrophages, dendritic cells, 
natural-killer lymphocyte) with various propensity to phagocytose and kill the yeasts [5,6]. 
Intracellular persistence in immune cells provides advantages to the fungus by allowing 
escape of the immune response and later dissemination through epithelial barriers [7,8]. 

With 1 million cases per year and 700,000 annual deaths, cryptococcosis is one of the 
most frequent invasive fungal infection, worldwide [9]. It occurs mostly in patients with 
immune defects, especially those with AIDS, but also non-HIV immunocompromised 
patients (sarcoidosis, solid organ transplantation, steroid or other immunosuppressive 
therapy) [10]. Cryptococcosis is a multifaceted pathology in terms of clinical presentation 
and outcome, with meningoencephalitis being the most frequent and severe presentation. 
Despite three months of adequate antifungal treatment, 15-20% patients will die from 
cryptococcosis [11]. In humans, the infection begins after inhalation of basidiospores or 
desiccated yeasts [12]. Primo-infection occurs in childhood with unrecognized 
pneumonia [13]. Yeasts are then controlled by the immune system through granuloma 
formation [14] and adaptive immunity with production of antibodies against C. 
neoformans antigens [13]. From this point on and until immunosuppression occurs, 
yeasts remain invisible. The disease is latent [15] and the yeasts are dormant as 
demonstrated epidemiologically [16,17]. When/if immunodeficiency occurs, yeasts 
reactivate and replicate probably in the lung and disseminate through the bloodstream to 
different organs. Crossing of the brain blood barrier leads to meningoencephalitis, the 
most common and more severe clinical presentation [12,18-20]. 

From an experimental point of view, the pathophysiology of the infection has been mainly 
studied in rats that are naturally controlling C. neoformans lung infection and more 
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extensively in mice that are susceptible to infection. Characteristics of the infection 
depend on both hosts and microbial factors. Fungal factors described as virulence 
factors influence the outcome of infection according to data obtained in the mouse model 
of cryptococcosis [21], but also in vitro [22] and in humans [23]. Microbial adaptation to 
the hosts is complex and had been studied globally in lungs using histopathology [24] 
and global transcriptome analysis upon amoeba [3] and macrophage [25] ingestion or 
upon early infection of mice and rabbits [26,27].

Isolates responsible for cryptococcosis are diverse in terms of species, serotype, mating 
type, and ploidy. This includes Cryptococcus neoformans variety grubii (serotype A) or 
variety neoformans (serotype D), and Cryptococcus gattii (serotype B and C). 
Cryptococcus neoformans propagates by budding and is also capable of sexual 
multiplication and same-sex mating, which contributes to the high diversity of the overall 
population even if asexual expansion is the predominant feature [28]. Haploid C. 
neoformans serotype A MATα isolates represent the most prevalent clinical isolates 
worldwide. Clinical isolates can be haploid or diploid, mating type alpha (MATα) or a [29]. 
In addition, single (one strain) or mixed (mixture of isolates belonging to various 
serotypes, mating types, genotypes and/or ploidies) infections have been described [30]. 
Cryptococcus spp. is present in the environment especially in soil, trees (Eucalyptus tree 
in Australia and mopane trees in Africa) and decaying wood [29]. A strong association 
between C. neoformans var. grubii and guano from Columba livia (feral pigeons) was 
found in the 1950s [31,32]. The relation with pigeons was also evidenced based on 
serological studies of pigeon fanciers that revealed a higher cryptococcal antibody 
compared to controls [33,34]. Genetic relatedness between environmental (pigeon 
droppings) and clinical isolates is observed [35-37]. It is demonstrated that Columba livia, 
that was domesticated 5,000 years ago and spread globally from Africa over the last 400 
years, is responsible for the worldwide distribution of C. neoformans var. grubii during the 
past centuries. Indeed, genetic divergence between cosmopolitan (low genetic diversity) 
and African (higher genetic diversity) is observed in environmental isolates and dated 
around 5,000 years ago [38,39]. Overall, clinical and environmental isolates harbor a huge 
diversity in terms of genotype [38] and phenotype [40,41]. From a evolutionary point of 
view, this gives advantage to the fungus to survive various complex environments ranging 
from soil or trees to mammalian hosts.
!!!!!!!!!!!!!!!!!!
 13
!                                                                                                                                                
1. Surviving humans 
Cryptococcosis is one of the most frequent fungal invasive infection in humans worldwide 
[9]. It occurs mostly in patients with immune defects, especially those with AIDS, but also 
in patients exposed to immunosuppressive therapy [10]. The pathophysiology of 
cryptococcosis is reminiscent of that of tuberculosis with a phase of latency. Reactivation 
can be observed years after primary infection usually through the respiratory route [15]. 
Upon immunosuppression, reactivation and dissemination can occur and the infection 
can be hard to control and treat despite active antifungal drugs [11].
!


1.a. The earlier, the longer 
Inhalation of aerosolized particles from soil (desiccated yeasts or basidiospores) is 
thought to be the major route of infection in humans [12]. Primoinfection with C. 
neoformans occurs mainly in immunocompetent children as demonstrated by serological 
studies with unrecognized (asymptomatic) infection as the main clinical presentation. The 
proportion of children immunized against C. neoformans increases with age. Acquisition 
of cryptococcal antibodies begins very early (1 year) with minimal reactivity of the sera. 
After 5 years, 70% of the children reacts with C. neoformans antigens [13]. However, the 
acquisition of anti-cryptococcal humoral immunity varies among geographic areas. 
Cryptococcal antibodies are very common in Bronx children but not in another New York 
areas (Dutchess County) or in Manila (The Philippines), another densely populated urban 
area [95]. Environmental exposure may depend on climatic and environmental factors 
(temperature, humidity, pigeon density), but also on human sociological factors (habitat 
conditions, financial resources). These findings supports epidemiological data revealing 
that cryptococcosis in immunocompromised individuals is more prevalence in some areas 
of the world, especially in Africa [9].
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Figure 1
Infection cycle of Cryptococcus (environment and host). The fungus survives in the environment within
soil (commonly contaminated with bird guano) and trees. Birds, especially pigeons (top-left panel ), may
have been responsible for worldwide dispersal. The fungus infects various animal hosts such as cats,
goats, and koalas (mid-left panel). It can also survive environmental predators such as insects, worms, and
amoeba (mid-left panel). In addition, it may interact with other microorganisms such as bacteria or other
fungi (bottom-left panel). The fungus establishes a human pulmonary infection through inhalation of its
spores or desiccated yeast cells from environmental sources. When the host becomes
immunocompromised, the fungus can reactivate from dormant, latent forms, and enter the central
nervous system (CNS). CNS infection represents th most severe form of hu an cryptococcosis.
supported by other similar studies showing
that genotypes of C. neoformans strains from
the same patient at different times and from
different body sites exhibited identical pat-
terns (157, 188).
In conflict with the single infection model,
some studies reported involvement of multi-
ple C. eoformans strains in a single pisode
of tococ osis and reinfecti n with novel
s rains in recurrent nfection as demonstrated
by RAPD analysis and DNA fingerprinting
(30).Mixed infections and acquisition of a dif-
ferent strain of C. neoformans have been previ-
ously reported, in some cases with isolates of
different serotypes (100, 110, 116, 150, 195,
196). It is unclear whether individuals with
mixed infections acquire the organism con-
comitantly or sequentially.
Because environmental sites can harbor
more than a single strain ofC. neoformans (49),
it seems plausible that initial infections might
be a mixture of isolates. However, the most
virulent or viable strain could eventually pre-
dominate and cause cryptococcosis when im-
munity of the host is compromised, giving
the impression of infection by a single strain
at the time of analysis. Moreover, the tech-
niques for routine typing of isolates are of
low sensitivity because most are performed
on one or two selected colonies from cer-
tain body ites. St ains pres t in low num-
bers or absent in certain tissues thus might
not be detected. Although some studies con-
clude that there is no body site preference
(157, 188), at least one early study showed that
there is strain preference for body sites (18)
and recent coinfection of strains of different
mating types also showed differences in or-
gan preference (165). Continued surveillance
of multiple primary isolates from patients
with cryptococcosis with improved tech-
niques may reveal that mixed infections occur
more commonly than is currently appreciated
(150).
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Schematic representation of the route of infection for cryptococcosis in humans 

(adapted from [29])
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Of note, C. gattii exposure and primoinfection does not follow the same epidemiological 
trends than C. neoformans based on studies realized in endemic areas in animals and 
humans [15].
!
1.b. Waiting for better days 
Serologic evidence of early cryptococcal immunity in immunocompetent hosts without 
recognized infection seems paradoxical with the very low frequency of cryptococcosis in 
immunocompetent hosts. However, immune control of the yeasts by immunocompetent 
hosts following primoinfection is possible with latency of the disease or complete 
clearance of the fungus as a consequence. Immunocompetent adults frequently exposed 
to C. neoformans had positive skin test but did not develop clinical disease [96]. Autopsy 
studies have raised the hypothesis that pulmonary granulomas could be the place for 
persistence since C. neoformans is observed in sub-pleural nodules and draining lymph 
nodes in immunocompetent and immunocompromised hosts [14]. Analysis of clinical 
isolates of C. neoformans var. grubii recovered in France from patients born in Africa 
(median of 110 months) prior to moving to France, revealed that genotypes from these 
patients clustered together, apart from those recovered from patients born in Europe [16]. 
This study is the main epidemiological evidence for dormancy of C. neoformans. The 
same conclusion is also drawn based on a serologic survey of solid organs transplant 
recipients (immunocompromised hosts) with analysis of sera obtained prior to 
transplantation and at the time they developed cryptococcosis. Indeed, early 
cryptococcosis after transplantation is observed preferentially in patients exhibiting 
serologic evidence of cryptococcal infection before transplantation [97]. Additionally, 
report of C. gattii infections in patients who travelled endemic areas years or month 
before, provides another evidence for dormancy before the Vancouver Island C. gattii 
outbreak [17].

However, symptomatic infection following primoinfection with or without further 
disseminat ion exists [98-100]. These acute infect ions occur mainly in 
immunocompromised or immunocompetent patients who were recently exposed to 
environmental sources of yeasts via massive inhalation or skin injury, leading to acute 
pulmonary [101,102] or to primary cutaneous [103] cryptococcosis, respectively. 

	 	 	 

1.c. Wake up and spread

The first manifestation of reactivation is observed in HIV-infected individuals for which 
asymtomatic cryptococcal antigenemia is detected [104-106]. Viable yeasts are not 
recovered from clinical sample at this step but treatment is mandatory to prevent 
symptoms and dissemination [107]. Pulmonary cryptococcosis is a well-described clinical 
entity that can evolve differentially depending on the immune status of the hosts. In 
immunocompetent hosts, C. neoformans does not usually disseminate, whereas the 
possibility of dissemination in immunocompromised patients is high. It is likely that 
dissemination occurs after reactivation of lung-persistent yeasts, crossing the lung 
epithelial barrier and disseminate through capillary blood [12]. However, pulmonary 
symptoms are not the principal clinical manifestation of cryptococcosis in 
immunocompromised patients. Indeed, most are diagnosed at the stage of dissemination 
or meningoencephalitis [11]. 
! !
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1.d. A thick-skinned fungus

Cryptococcosis is characterized by a high frequency of central nervous system (CNS) 
involvement with positive cerebrospinal fluid (CSF) and dissemination through blood. 
Cryptococcosis is more severe in male, HIV-positive patients, and those infected with 
serotype A [11]. Acute cryptococcal meningoencephalitis is always fatal without antifungal 
therapy [20]. It requires an antifungal therapy induction based on amphotericin B and 
flucytosine for a minimum of 2 weeks [108]. Mycological failure after 2 weeks of induction 
is recognized as a factor of bad prognosis, which requires continuation of the induction 
therapy [108]. Mycological failure is independently associated with initial dissemination, 
high serum antigenemia (>1:512) and lack of initial flucytosine treatment [11]. The three-
months mortality rate during the management of acute cryptococcal meningoencephalitis 
approximates 20% despite adequate treatment. It is still not clear whether this mortality 
rate is due to individual’s immune status, genetic factors [109], fungal determinants or a 
combination of them.
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
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2. Surviving host cells 
Cryptococcus neoformans is a facultative intracellular pathogen [24]. Interaction of C. 
neoformans with host cells can lead to phagocytosis, with occasional escape to the 
extracellular space (vomocytosis), and possible yeast transfer between phagocytic cells 
[28,42]. Cryptococcus neoformans is capable of replication within the phagolysosome, 
sometimes associated with host cell lysis [29,42]. These phases have been well studied in 
different models of interaction with host cells but mainly within macrophages.
!


2.a. To be or not to be...phagocytosed (Phase 1) 
The uptake of C. neoformans cells is assumed by professional phagocytes. Immune 
cells have various propensities to phagocytosis. Neutrophils [43,44], monocytes/
macrophages [45] and dendritic cells [46] are well known professional phagocytes that 
are able to deal with C. neoformans as well as the drosophila S2 cells [47]. The 
phagocytic capacities of these cells vary [47]. Various phagocytic capacities in rat 
macrophages originated from various sites (pleural, peritoneal, alveolar macrophages) [48] 
or in mice macrophages (alveolar or peritoneal) [5] are observed when challenged with a 
given C. neoformans strain. Intracellular yeasts have been observed in lungs. Fungal 
uptake depends on the equilibrium between host factors mainly present at the surface of 
immune cells and microbial factors that are produced by the yeasts to escape 
phagocytosis.

Phagocytosis is mediated by receptor activation that allows cytoskeletal 
modifications of the host cell to internalize the yeasts. Receptors are opsonic, such as Fc 
receptors or complement receptor family, or non-opsonic, such as Dectin-1, CD11b, or 
 17
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seems to provide considerable protection in 
the phagosome by promoting the oxidation 
of phagosomal iron to Fe(III), with a con-
sequent reduction in microbicidal oxidant 
formation.
C. neoformans is thought to have a 
remarkably robust antioxidant system 
that can protect it against many stresses, 
including attack by phagocytic cells63. For 
example, it has four catalase genes, which, 
even when deleted, do not confer increased 
susceptibility to oxidants in vitro, attesting 
to the existence of other parallel antioxidant 
mechanisms64. By contrast, two enzymes that 
confer resistance to nitrogen-related oxi-
dants, flavohaemoglobin denitrosylase and 
S-nitrosoglutathione (GSNO) reductase, are 
important for virulence and intracellular sur-
vival65. Another important system for the  
resistance of oxidative stress comprises  
the thioredoxin proteins, which seem to be 
important for virulence and survival in mac-
rophages66. There are two genes for superox-
ide dismutase, both of which are important 
for virulence and resistance to phagocytic 
cells67–69. Yet another non-enzymatic antioxi-
dant system is the production of mannitol, 
which can protect cryptococcal cells from 
neutrophil oxidative killing by scavenging 
for oxygen-related oxidants70. In addition, 
sphingolipid synthesis, and an enzyme that is 
involved in the metabolism of fungal inosi-
tol sphingolipids, confers resistance against 
macrophage antimicrobial mechanisms and 
promotes intracellular survival71. 
A unique aspect of the C. neoformans 
intracellular pathogenic strategy is the 
release of large numbers of polysaccha-
ride-filled vesicles into the cytoplasm of 
infected macrophages49,52. These vesicles 
seem to bud from the phagosomal mem-
brane, and are not found in cells that have 
ingested acapsular cryptococcal strains. 
The mechanism of vesicle formation 
and the fate of cytoplasmic vesicles are 
unknown. However, they accumulate in 
such large numbers that they may com-
mandeer large amounts of cellular mem-
brane material, and this could compromise 
host cell survival. C. neoformans has 
recently been shown to export its polysac-
charide to the cellular exterior in vesicles72. 
Consequently, it is conceivable that the 
cytoplasmic vesicles that accumulate in 
infected cells are related to, or form from, 
these fungal vesicles. Proteomic analysis 
has shown that these export vesicles also 
harbour multiple virulence-associated 
proteins, which, combined with their 
polysaccharide and phospholipid con-
tents, suggests that they can function as 
virulence-factor delivery bags73. Whether 
the polysaccharide-containing vesicles 
are released from infected macrophages 
to affect neighbouring cells is unknown. 
Similarly, in bacteria, mycobacterial lipids 
are released from infected macrophages74. 
Escape from phagocytic cells
Cavanaugh and Randall proposed that the 
death of macrophages that harbour phago-
cytosed Y. pestis provided an escape mecha-
nism for the bacteria17. Although plausible, 
there is no other evidence for a mechanism 
by which Y. pestis exits macrophages. By 
contrast, C. neoformans ingestion by mac-
rophages has at least three outcomes: death 
of the fungus, to produce fungal progeny, 
which are released by host cell lysis, and 
fungal exit from the infected cell through 
single-cell exocytosis or phagosomal extru-
sion. Unchecked replication can lead to 
catastrophic lysis of the macrophage and 
the release of viable fungal cells. However, 
perhaps the most remarkable outcome is the 
exit of C. neoformans cells from the infected 
macrophage, either singly or in a massive 
burst following the extrusion of a phago-
some that contains numerous yeast forms. 
C. neoformans exocytosis seems to be asso-
ciated with homotypic phagosome fusion 
and actin depolymerization. C. neoformans 
also has the capacity to spread from one host 
cell to another without exiting to the extra-
cellular space75,76. Whether this phenomenon 
is a form of phagosomal extrusion into a 
neighbouring cell or a specific fungal strategy 
to infect neighbouring cells in metazoan 
organisms is unknown. 
The case for convergent evolution
Convergent evolution is a process by which 
genetically distant organisms manifest simi-
lar traits in adaptation to similar environ-
ments or selection pressures. An example 
of convergent evolution is the anatomical 
adaptations to the problem of flight by birds, 
bats and insects. Y. pestis and C. neoformans 
are thought to have diverged 1.5–2.0 bil-
lion years ago, when eukaryotes emerged. 
Because animals do not appear in the evolu-
tionary record until approximately 400–500 
million years ago, any similarities in intracel-
lular pathogenic strategy must have arisen 
long after the divergence of prokaryotes and 
eukaryotes. Mammalian phagocytic cells, 
such as macrophages, have a formidable 
array of antimicrobial properties, and can be 
envisaged as a specific ecological niche in an 
animal host.
By comparing the interaction of Y. pestis 
and C. neoformans with host cells, it is evi-
dent that both microorganisms have found 
Figure 2 | Model for the interaction of Cryptococcus neoformans with macrophages. 
a | A schematic of the interaction of C. neoformans with macrophages. The process s arbitrarily sh wn 
as five phases with four possible outcomes. In phase 1, C. neoformans is opsonized with specific 
antibody or complement and then ingested. After ingestion, macrophages can kill or inhibit the 
replication of C. neoformans (outcome 1). In phase 2, C. neoformans replicates inside macrophages 
and occasionally escapes to the extracellular space (outcome 2). In phase 3, a giant phagosome forms 
from intracellular replication or homotypic phagosomal fusion. In phase 4, two possible outcomes 
result i  the exit of C. neoformans cells to the extracellular space through phagosome extrusion or 
host cell lysis. b | An electron micrograph of a macrophage with numerous yeast cells in a giant 
phagosome (magnification of x5,000). 
PERSPECT IVES
NATURE REVIEWS | MICROBIOLOGY  VOLUME 7 | FEBRUARY 2009 | 169
)''0DXZd`ccXeGlYc`j_\ijC`d`k\[%8cci`^_kji\j\im\[
Schematic representation of the different phases and outcomes during Cn/host cell interaction 

(adapted from [42])
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mannose receptors. The latter recognize the pathogen through pathogen associated 
molecular patterns (PAMPs) present at the fungal surface. In vitro, phagocytosis is 
inefficient in the absence of opsonin [49] making necessary the adjunction of an opsonin 
to study phagocytosis of C. neoformans. Antibody-mediated opsonization appears to be 
most efficient [50] compared to complement-mediated opsonization. Interestingly, 
surfactant protein D and A produced in the lung acts as an opsonin in vitro in poorly 
encapsulated yeasts [51,52] but seems to be less efficient in fully encapsulated yeasts 
[53,54]. Paradoxically, surfactant protein D facilitates infection [55].

Non-opsonic receptors and their role in cryptococcosis are still not well established. 
When dealing with basidiospores, phagocytosis by alveolar macrophages takes place 
though interaction between beta-glucan, Dectin-1 or CD11b receptors [56]. However, 
Dectin-1 deficient mice are similar to wild type mice in terms of clinical course of the 
infection and cytokine production, suggesting that Dectin-1 plays a minor role for the 
development of protective immunity against C. neoformans [57]. At the opposite, the 
mannose-receptor plays a role in adaptive immunity against C. neoformans by stimulation 
of CD4 T cells proliferation, but it is not involved in C. neoformans uptake by dendritic 
cells [58].

Fungal factors that make C. neoformans resistant to phagocytosis are multiple. 
Polysaccharide capsule is the main one. Glucuronoxylomannan (80-90%) as the main 
component of the capsule is not recognized by the phagocyte [59,60] and dissimulates 
PAMPs to the phagocytic cells acting as a physical barrier [61,62]. Other factors are 
involved in resistance to phagocytosis. The secreted anti-phagocytic protein (App1) 
blocks complement-mediated and not antibody-mediated phagocytosis [63]. App1 binds 
to the CD11b receptor and blocks complement binding to the receptor [64]. Though the 
screening of a library of 1201 gene knock-out C. neoformans mutants, the transcription 
factor Gat201 (GATA family transcription factor 1) is identified as a capsule independent 
anti-phagocytic protein [65]. Gat201 plays a pleiotropic role in C. neoformans as it 
participates to the formation of capsule and melanin. Gat201 regulates Gat204 (a 
transcription factor) and Blp1 (Barwin like protein 1) to maintain anti-phagocytic activity 
[66]. Yeast size is important for phagocytosis. Indeed, yeasts called titan cells with 25-30 
µm for cell body size and 50-100µm with capsule, that are generated in lungs, are 
resistant to phagocytosis [67-69].
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have variable size ranging from Titan cells (big size, enlarged cell wall, left) 

to normal size (budding yeast, right)
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2.b. The less you have, the more you will be (Phase 2/3) 
The ability of C. neoformans to multiply intracellularly has been known for a long time. In 
vitro, intracellular yeast in human macrophages grow faster than extracellular yeasts [45]. 
In vitro, replication is observed in activated J774.16 macrophages as soon as 2 hours 
after ingestion and is associated with accumulation of vesicles filled with polysaccharide 
within the macrophage cytoplasm and phagosome membrane disruption leading to 
increased phagosomal pH [70]. Th2 cytokine enhanced intracellular proliferation 
compared to Th1 or Th17 ones [71].  In vivo, this phenomenon appears 24 hours after 
mice inoculation with increasing number of yeasts per phagosome. Budding is also more 
frequent within alveolar macrophages than in the extracellular space. Intracellular 
replication is associated with cytotoxicity and intracellular polysaccharide production [24].

!
2.c. Dead end (outcome 1) 
Killing is the natural role of professional phagocytic cells. The maturation process leading 
to the acidification of the initial single-membraned phagosome by fusion of phagosome 
with lysosomes happens after C. neoformans phagocytosis [72] as observed by lamp1 
(CD107a, type I transmembrane glycoprotein) recruitment [73]. Interestingly, C. 
neoformans cells replication is enhanced by acidification and antifungal activity is 
observed after alkalization of the phagosome. Many virulence factors, such as melanin 
production via laccase activity, protect yeasts against antifungal activity of macrophages. 
Despite that C. neoformans expends numerous mechanisms based on anti-oxidative 
enzymes to avoid killing [74], dead yeasts are still observed and can be measured by 
colony forming unit (CFU) counts or flow cytometry upon macrophages internalization 
[75-77]. Indeed, apart from pH acidification, antimicrobial activity is also achieved by 
production of respiratory burst with generation of reactive oxygen species (ROS), addition 
of anti-microbial peptides, proteases and nutrient starvation leading to a global 
 19
Cryptococcus neoformans proliferates within J774 macrophages 

6 hours after after phagocytosis

(Mother yeast cells are bright blue and daughter yeast cells are less fluorescent)
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antimicrobial activity [73,78]. Alveolar macrophages are able to kill C. neoformans cells by 
non-oxidative mechanisms, paradoxically, preferentially in encapsulated rather than 
acapsular yeasts [79]. Cryptococcus neoformans killing occurs also extracellularly after 
contact with IFNγ-activated macrophages suggesting secretion of antifungal peptides by 
macrophages [80].

In nature, C. neoformans cells encounter unicellular or multicellular predators such as 
Paramecium, amoebas or Caenorhabditis elegans. The proportion of killed C. neoformans 
cells is higher in Paramecium [4] than in amoebas [81] or nematodes [82].
!
2.d. An emetic yeast (outcome 2/3) 
Expulsion of yeasts without lysis or dramatic damages of macrophages is observed in 
vitro [83-85] and demonstrated in vivo [86]. This non-lytic exocytosis phenomenon was 
initially called vomocytosis. It has also been observed with Candida albicans [87]. The 
mechanisms that support this phenomenon are not completely understood. Release of 
the C. neoformans cells could results from stochastic fusion between phagosome and 
plasma membrane plasma and phagosome membranes fusion [88], since vomocytosis 
occurs preferentially when the phagosome is filled with multiple yeasts [85]. However, 
vomocytosis is rarely observed with mutants deficient in Plb1 secretion (plb1∆) [89], killed 
yeasts or intracellular beads suggesting an active phenomenon that depends on 
physiological characteristics of some strains [85]. Vomocytosis is also dependent on the 
activation state of the macrophage with a reduced occurrence in Th2 cytokine-treated 
macrophages compared to TH1 or Th17 treated cells [71]. On the opposite, alkalization of 
phagosomes induced increased rate of vomocytosis [84,86]. Although host actin 
cytoskeleton is not required for vomocytosis, a possible mechanisms based on repeated 
cycles of actin polymerization (called actin flashes) regulated by the WASH-Arp2/3 
pathway could explain this phenomenon [88]. Apart from exocytosis, cell to cell transfer 
of C. neoformans between two macrophages has also been observed in vitro [90,91].
!
2.e. A toxic marble bag (outcome 4) 
As observed in vivo, extracellular yeast are associated with cell debris within the first 24 
hours after inoculation suggesting that intracellular yeasts that began to replicate 2 hours 
after inoculation are able to lyse the phagocytic cells with release of living yeasts into the 
extracellular space as a consequence [24]. Replication followed by cell lysis is also 
reported in vitro in human macrophages [45] or human microglia [92]. Polysaccharide 
vesicles accumulation and phagosomal membrane disruption could lead to instability and 
finally disruption of the cellular membrane. Macrophage killing could also result from 
apoptosis since galactoxylomannan is shown to induce Fas/FasL-mediated apoptosis in 
macrophage [93] as well as B lymphocytes [94].
!!!!!!!!!
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3. Adapting to hostile environments 
Cryptococcus neoformans and C. gattii are able to survive in, to adapt to and to lyse the 
host cell or disseminate into infected organisms. Theses features are the result of fungal 
factors selected during the evolution due to the selection pressure in Cryptococcus 
environment. Three main virulence contributes to the infectivity of these yeasts: the 
production of a polysaccharide capsule [110], the ability to grow at 37°C [111], and the 
production of melanin by laccase [112]. The capsule provides anti-phagocytic [60] and 
immunomodulatory properties [113]. Key enzymes are involved also in the virulence: 
phospholipase B [114], urease [115], superoxide dismutase [116], proteases [117]. 
Cryptococcal cells have a specific delivery system for excreting virulence factors via 
vesicles called ‘virulence factors delivery bags’ [118]. The release of these bags is the first 
cryptococcal armamentarium to prevent adapted immune response [119]. Apart from 
well-identified virulence factors, global transcription analysis identified the global 
mechanisms that support fungal adaptation to hostile environments.
!
3.a. Adapting to natural predators 
Natural predators of C. neoformans in nature are unicellular (Amoebas, Paramecium) or 
multicellular (nematodes or insects) organisms. Amoebas of the genera Acanthamoeba 
feed on bacteria or fungi [120,121]. They are present in soil and fresh water and were 
initially identified as cryptococcal culture contaminant. Cryptococcus neoformans can be 
phagocytosed [122] and can replicate in Acanthamoeba castellanii [2] or the social 
amoeba Dictyostelium discoideum [81], leading at the end to the killing of the amoeba. In 
comparison, these features are not observed with Candida albicans and Saccharomyces 
cerevisiae. Virulence factors such as capsule, melanin or phospholipase are needed to 
resist phagocytosis and oxidative burst and to replicate in amoebas. At the opposite, 
Paramecium tetraurelia or Paramecium aurelia are organisms that are able to ingest and to 
kill C. neoformans within the first 24 hours of incubation [4]. Other Paramecium species 
such as Paramecium multimicronucleatus has a fungistatic but not fungicidal effect on C. 
neoformans [4].

Multicellular invertebrate hosts can interact in theory with C. neoformans in nature. The 
free-living nematode Caenorhabditis elegans can use Cryptococcus spp. as the sole 
source of food [82]. Cryptococcus neoformans and not Cryptococcus laurentii or 
Cryptococcus kuetzingii (species that are known to interact with C. elegans in nature) is 
able to kill the nematode by accumulation within the gastrointestinal tract of the 
nematode. This phenomenon is dependent of virulent factors. The caterpillar of the 
greater wax moth (Galleria mellonella) model has also been developed to easily study 
virulence at room temperature. It appears that C. neoformans can proliferate inside the 
hemocoel and kill the caterpillar even if C. neoformans are phagocytosed by G. mellonella 
hemocytes.

Drosophila melanogaster has also been challenged with C. neoformans [123]. 
Interestingly, flies are resistant to C. neoformans when inoculated in the hemolymph, 
whereas they are susceptible when ingested [124]. This is explained by the differential 
expression of the toll-like receptors in fly tissues.

C. neoformans adaptation to predators has been analyzed upon Acanthamoeba 
castellanii ingestion in terms of whole transcriptome modifications [3]. Genes encoded 
well-known virulence factors are up regulated, as well as genes involved in nutrient 
transporters, in general metabolism and stress response. Genes involved in transcription 
and translation and ergosterol biosynthesis are down regulated. Parallel analysis of the 
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transcriptional modification upon amoeba or macrophage internalization revealed that 
83.8% of yeasts genes are modulated similarly. The metabolic modifications are very 
similar between both conditions with a switch towards gluconeogenesis, fatty acids 
degradation, and glyoxylate cycle. Furthermore, PTP1 (Polyol transport protein 1) gene 
involved in 5,6-carbon polyol transport is up regulated upon macrophages and amoeba 
internalization. This study reinforces the hypothesis in which the virulence in mammalians 
originated from interaction of yeasts with environmental protozoan predators [3].
!
3.b. Adapting to mammalian hosts 
Immunity against C. neoformans is different from a mammalian host to another. Rats has 
been demonstrated to be naturally resistant to cryptococcal infection [125]. For mice, the 
genetic background is influencing the course of the infection. For example the 
pathophysiology of cryptococcosis in BALB/c and CBA/J inbred mice is different [126]. 
Outbred mice can also be used with the idea to mimic the natural diversity of the host to 
study immune response to infection [127]. 

The C. neoformans (H99 strain) translational modifications have been studied in the lungs 
of A/Jcr mice after early infection (8 – 24 hours) [26] and in the central nervous system 
(CNS) of New Zealand White rabbits, both using the SAGE (serial analysis of gene 
expression) methodology [27].

In lungs, a remodeling of the yeast central carbon metabolism is observed with particular 
stimulation of the glyoxylate pathway, gluconeogenesis, ß-oxidation and amino acids 
biosynthesis [26]. Indeed, C. neoformans seems to adapt to glucose-limited environment 
by exploiting alternative sources of energy such as acetate, lactate, fatty acids or amino 
acids. Transporters for monosaccharides, iron, copper and acetate and stress response 
proteins are also over-expressed suggesting nutrient restriction and hostile host 
environment.

At the opposite, the C. neoformans transcriptional patterns in the CNS, is directed toward 
protein biosynthesis (ribosomal proteins, translation elongation, translation initiation), 
protein degradation (proteasome pathway, secreted proteases) and response to stress 
(heat shock proteins). Up-regulation of gene involved in energy production is also 
observed [27].

Overall, C. neoformans seems to adapt well in CNS with a typical translational patterns of 
multiplication compared to lungs where up-regulation of genes involved in resistance to 
nutrient-limitation is predominant. !
3.c. Adapting to immune response 
Whole gene expression analysis using homemade microarrays chips was used to 
examine C. neoformans (H99 reference strain) adaptation to the intracellular environment 
of the murine J774 macrophages [25]. The up-regulated genes are involved in membrane 
transport for hexoses, amino acids, iron, ammonium, nicotinic acids and phosphates. 
Genes implicated in the metabolism of lipids, autophagy, and peroxisomes are also 
elevated. Response to oxidative stress is observed by up-regulation of flavohemoglobin. 
Components of the cAMP signal transduction pathway are also more expressed. Down-
regulation of translational initiation, elongation and ribosomal RNA processing proteins 
are observed. Comparable results are obtained using serial analysis gene expression 
(SAGE) [128] and upon phagocytosis of rat peritoneal macrophages with induction of the 
same metabolic pathways in C. neoformans [129]. This is also consistent with what is 
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found in Candida albicans in response to macrophage environment [130].

The adaptation to humoral immune response as also been studied. Anti-cryptococcal 
antibody response plays a role in the immune response during cryptococcosis [131,132]. 
Binding of protective antibodies to the cryptococcal surface (capsule) induced up-
regulation of the fatty acids biosynthesis pathway and ergosterol synthesis, and down-
regulation of protein involved in translation functions [133]. The translational response is 
different depending on the type of antibody and the location of the epitope. This suggests 
that C. neoformans could develop strategies to escape adaptive immunity during 
infection.
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
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4. Diversity: a powerful force for C. neoformans survival 
Confronted with the need to survive different hosts in different environments, C. 
neoformans has selected ready-made virulence traits [1]. From a deterministic point of 
view, C. neoformans population needs also diversity to survive predators harboring 
different killing propensity. The plasticity of the genome C. neoformans could lead to this 
diversity [134]. Cryptococcus neoformans and C. gattii are haploid organisms that can be 
found as diploid organisms both in nature and in hosts [30,135]. Generation of hybrids is 
possible between the varieties grubii (serotype A) and neoformans (serotype D) [135,136] 
but also between C. neoformans and C. gattii illustrating again this plasticity [137].
!
  
!
Diploidization of serotype A or D is also possible and can be recovered from clinical 
specimens [30,138]. Clinical and environmental isolates of C. neoformans are highly 
diverse and can be classified in 3 genetic subpopulations based on AFLP and MLST 
methods including VNI, VNII, VNB with VNI as the most prevalent and ubiquitous subtype 
[139,140]. Overall, this diversity impacts the interaction between various hosts and C. 
neoformans isolates. Experimental data are mostly obtained using reference strains such 
as H99 (serotype A) or JEC21, JEC20 or NIH52D (serotype D). However, the few studies 
that use clinical isolates in addition to reference strains suggest even more diversity.
!!!!
from other sub-Saharan Africa countries, Europe, and
North America was much smaller (2.8% AFLP and
2.9% MLST), indicating little differences among these
populations.
To further evaluate genetic divergence among the
po ulations, Wright’s fixation indexes (FST) were cal-
culated for pairs of putative populations. FST has a
theoretical minimum of 0 (indicating no genetic di-
vergence) and a theoretical maximum of 1 (indicating
fixation for alternative alleles in different popula-
tions); however, the index rarely reaches the maximum
of 1, and an FST-value .0.15 denotes considerable
differentiation.
For all of the five phylogenetically defined popula-
tions, the pairwise FST-values were above .0.25 (P ,
0.001, Table 6), indicating significant genetic diver-
gence among these populations. Conversely, when the
populations were defined according to the geographi-
cal origins of the isolates, the population romBotswana
was significantly divergent from the other samples from
Africa, North America, and Europe (FST $ 0.18; P ,
0.001, Table 7). However, there was no significant dif-
ference among the populations from non-Botswanan
Africa, North America, and Europe. In both sets of FST
calculations (Tables 6 and 7), the AFLP and MLST data
yielded the same results.
Figure 2.—(A) Genetic
relationships of MLST ge-
notypes among the 102
isolates of C. neoformans se-
rotype A visualized by the
neighbor-joining dendro-
gram. Numbers on each
branch indicate the boot-
strap values .50%, based
on 500 replications. Vertical
lines represent strains with
identical genotypes. The
clades labeled A1–A5 and
A10 are AFLP genotypes
that correspondto theAFLP
genotypes listed in Table
1. VNB-A and VNB-B are
two subpopulations within
the VNB group described
previously (Litvintseva
et al. 2003). Isolates from
Botswana are shown in red,
and isolates with the MATa
mating type are shown in
boldface type and desig-
nated with ‘‘a.’’ (B) Strict
consensus of eight maxi-
mum-parsimony trees in-
ferred from the combined
gene genealogies of the
C. neoformans serotype A
MLST genotypes and
rooted with sequences of
the JEC21 serotype D strain
(Loftus et al. 2005). Only
unique genotypes are in-
cluded. However, large gaps
in the alignments of nucleo-
tide sequences from strains
of serotype A and the sero-
type D strain reduced the
numberofuniquegenotypes
from 57 to 27. Ten strains
that were inconsistently
placed within the gene gene-
alogies of the 12 genes were
excluded from the analysis.
CI, consistency index; RI, re-
tention index.
Sequence Typing of C. neoformans 2231
Phylogenetic tree representing the genetic diversity of C. neoformans isolates (serotype A) 

obtained from various countries (adapted from [139])
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4.a. Facing predators in nature

Diversity of C. neoformans phenotype upon interaction with various predators is 
observed. Phagocytosis [141] and killing [2] of A. castellanii varies among isolates (clinical 
and reference strains). The same features are observed upon interaction with the social 
amoeba Dictyostelium discoideum [81]. Vomocytosis can also been observed with 
Acanthamoeba castellanii with a rate that is dependent on the strain and the viability of 
the yeasts [141]. Upon interaction with Paramecium, the sensitivity of C. neoformans 
strains to this organism vary in comparison with H99.

Cryptococcus neoformans and not Cryptococcus laurentii or Cryptococcus kuetzingii 
(species that are known to interact with Caenorhabditis elegans in nature) is able to kill C. 
elegans [82]. Virulence in this model varies among C. neoformans isolates regardless of 
the serotype [82]. Of note, environmental strains of C. neoformans are also pathogenic for 
C. elegans. In the caterpillar of the greater wax moth (Galleria mellonella) model, although 
all strains tested are able to kill the caterpillar, H99 is more virulent [142]. Killing of D. 
melanogaster is also more important for H99 compared to clinical isolates of serotype A 
or serotype D [123].
!
4.b. Facing various mammalian hosts 
In mice lungs, the proportion of yeasts in the intracellular or extracellular spaces varies 
with the duration of infection and the strain inoculated [24]. The nature of the infecting 
particles inoculated to hosts is important. Basidiospores from a serotype D strains are 
100 fold more infective that the yeasts form [143]. This had not been reproduced using 
serotype A strains [144]. Indeed, basidiospores compared to yeasts inoculation lead to 
lower CFU in lungs at early time points after inoculation [56].

The nature of the strain of Cryptococcus spp. used to inoculate mice will also influence 
the course of the infection, as observed with two environmental strains of C. neoformans 
[145]. Differences of virulence have been observed when isolates of serotypes A, B, C, D 
are compared [146]. Thus, the pathophysiology of the infection between C. neoformans 
H99 and C. gattii R265 is different. H99 is more prone to induce meningoencephalitis and 
less to induce lung injury compared to R265 [147]. Variation of CFU in lungs is also 
observed in different C. gattii strain [22,148]. Difference in virulence is observed 
comparing clinical isolates of C. neoformans recovered from AIDS patients [40], or 
environmental strains [149] or comparing clinical to environmental strains with clinical 
isolates harboring higher virulence than environmental isolates [37].
!
4.c. Facing immune cells 
When challenged with various C. neoformans strains, variation of phagocytic index is 
observed using single macrophage cell-line of rats [150] or mice [49], or human 
neutrophils [151]. Phagocytic index of human neutrophils varies from 0.7 to 98 ingested 
yeasts per 100 neutrophils considering various clinical isolates. In comparison, 
phagocytic index of different donors facing the same C. neoformans strain does not vary 
in the same proportion [44]. As a result of variation in the phagocytic index, killing of 
various C. neoformans clinical isolates is different [76,152]. Direct activity of T 
lymphocytes and natural killers against C. neoformans is different in two different isolates 
[153].

Variation in the intracellular proliferation rate in J774 mouse macrophages is also 
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observed in different strains of C. gattii, with the clonal VGII isolates (responsible for the 
Vancouver island outbreak) harboring higher proliferation ratio compared to C. gattii from 
other genotypes [22]. The authors associated this phenotype with a higher mitochondrial 
activity. This study did not demonstrate if higher mitochondrial activity is the origin or the 
consequence of the observed phenotype. Isolates from VGIIa and VGIIc C. gattii 
genotypes have higher IPR than those from VGIIb genotypes with additional variation of 
IPR between isolates within the VGIIb population [154]. In addition, vomocytosis is 
observed preferentially with some specific strains [155].
!!!! !
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Species, serotype, genotype diversity of C. neoformans is established, but the diversity of 
adaptation of the yeasts to various environment is partially understood. It is still not clear 
whether the variable clinical presentation and outcome of cryptococcosis is related to the 
individual’s immune status, some genetic factors [109], fungal determinants or a 
combination of them. The role of fungal determinants in the outcome of cryptococcosis is 
usually studied using mutants generated from reference strains, and rarely with clinical 
isolates. For C. gattii, a specific genotype (VGII, responsible for the Vancouver Island 
outbreak) is associated with increased intra-macrophagic yeast proliferation and virulence 
in mice compared to other genotypes [22]. However, for C. neoformans, the influence of 
genotypes or phenotypes diversity on pathogenesis has not yet been established.

Our objective was here to understand how fungal diversity could impact the 
pathophysiology of the infection by C. neoformans. We took advantage of the well-
characterized collection of clinical isolates and corresponding clinical data (CryptoA/D 
study) [11], a clinically relevant murine model of disseminated cryptococcosis and 
developed new tools to address this question. We then focused on C. neoformans 
adaptation to host during infection with the hypothesis that a specific population 
representing dormant cells could be identified.	  
!
!
!
!
 29
!                                                                                                                                                
!
!!!!!!!!
!
!
!
Materials and Methods 
 30
!                                                                                                                                                
Cell line.

The J774.16 cell line (J774) was purchased from the American Type Culture Collection to 
study the interaction of Cn clinical isolates with macrophages. J774 is a murine 
macrophage-like cell line derived from a reticulum sarcoma. Cells were maintained at 
37°C in the presence of 5% CO2 in DMEM supplemented with 10% heat-inactivated fetal 
calf serum (FCS) and 1% penicillin/streptomycin (fresh medium) (all from Invitrogen). Cells 
were used between 10 and 35 passages. 
!
C. neoformans strains.

A panel of 54 C. neoformans clinical isolates was selected. All isolates were recovered 
from cerebrospinal fluids and responsible for single infection (one isolate/one genotype/
one infection), as opposed to mixed infection  [30]. All isolates were collected during the 
CryptoA/D prospective study [11]. This study was approved and reported to the French 
Ministry of Health (registration # DGS970089). For each isolate, the patient’s background, 
clinical presentation, outcome of infection, and various biological parameters were 
available (Table 1). One single colonies (ClinCn) from each clinical isolate was frozen in 
glycerol 40% at -80°C and used thereafter. All ClinCn were characterized as haploid, 
serotype A MAT using previously described methods [30]. Before each experiment, yeasts 
were first cultured on Sabouraud dextrose agar (SDA) medium and then subcultured in 
liquid yeast extract-peptone-glucose medium at 30°C at 150 rpm for 22 hours (standard 
YPD culture). All isolates were tested blind to the clinical parameters. Two ClinCn isolates 
(AD1-83a and AD1-07a) were selected based on their various virulence characteristics 
[23] for specific experiments.

Mutant strains (all derived from H99) lac1∆ (lacking laccase 1, Lac1) [156], vps34∆ 
(lacking the PI3 kinase, Vps34) [157], vad1∆ (lacking the DEAD-box RNA helicase, Vad1) 
[158] (kindly donated by P. Williamson, NIH, Bethesda, MD), and app1∆ (lacking the 
antiphagocytic protein, App1 [63], that binds the CR3 and CR2 receptors on phagocytic 
cells [64]), ipc1∆ (in which inositol-phosphoryl ceramide synthase, Ipc1, is down-
regulated) [159] (kindly donated by M. Del Poeta, Charleston, SC), were also used. The 
reference strain H99 (serotype A, MATalpha, haploid) (kindly donated by J. Heitman, Duke 
University, NC) was used as reference in all experiments.
!
Reagents and C. neoformans labeling.

Calcofluor white dye (CALCO) (Fluorescent brightener 28, Sigma) specifically stains chitin 
contained in the cell wall of some eukaryote microorganisms, and was used to label 
yeasts. Yeast cells were collected from standard YPD culture, washed twice and 
resuspended in phosphate buffered saline (PBS) (Invitrogen) at 5x106 to 2x107 per ml. The 
cells were then incubated with CALCO at 10μg/ml in PBS for 10 min in the dark at room 
temperature and then washed twice in PBS. In preliminary experiments, we checked that 
the in vitro growth curves strains were similar (identical slopes) for CALCO-stained and 
unstained yeasts, except for lac1∆ for which growth decreased after CALCO staining 
(data not shown). To assess the evolution of CALCO-fluorescence during multiplication, 
CALCO-stained C. neoformans (106/ml) cultured in standard YPD were analyzed using 
fluorescence microscopy (Zeiss Axioscope A1, 4′,6-diamidino-2-phenylindole (DAPI) filter) 
and flow cytometry at various incubation times. E1, a murine IgG1 monoclonal anti-
capsular polysaccharide antibody (E1 mAb) was used as an opsonin [160]. Fluorescein 
isothiocyanate (FITC)-labeled horse anti-mouse IgG (anti-IgG–FITC) (Vector Laboratories) 
and allophycocyanin (APC)-labeled goat anti-mouse IgG (anti-IgG–APC) (BD Pharmingen) 
were used at 1:100 for 20 min-incubation.

 31
!                                                                                                                                                
5-chloromethylfluorescein diacetate (CMFDA) (CellTracker Green CMFDA, Life 
Technologies) is a dye that needs two enzymatic steps and glutathione to acquire 
fluorescence (FITC) properties. It is commonly used to quantify glutathione in mammalian 
cells [161,162], and has been employed for long terms tracking of C. neoformans in vivo 
[86]. The stock solution in anhydrous dimethyl sulfoxide (DMSO) was diluted at 10µM in 
PBS. 

TO-PRO-3 iodide  (TOPRO),  (Invitrogen), diluted at 10µM in PBS, was used to stain 
nucleic acids of yeasts with disrupted membrane (dead yeasts) and then analyzed in the 
allophycocyanin (APC) channel. 

Preliminary experiments showed that combining TOPRO and CMFDA for 30 min-
incubation at 37°C without agitation was efficient over yeasts concentrations ranging from 
106 to 107/mL and in the presence of tissue debris. CALCO staining was always 
performed on living cells prior to all other stimuli whereas CMFDA/TOPRO assay followed 
them. These stainings did not alter yeasts viability (data not shown).

In specific experiments, yeasts were subjected in vitro to various stimuli to test the 
glutathione-mediated stress response and then subjected to CMFDA/TOPRO assay at 
different time points. The stimuli included (i) pure water; (ii) hydrogen peroxide (Sigma) 
adjusted to 2 mM in water [163]; (iii) fresh medium or yeast nitrogen base medium (YNB) 
that represents a non optimal culture media for yeasts based on preliminary experiments 
(data not shown); (iv) heat at 65°C for 2 hours that results in 99.9% of dead yeasts. All 
stimuli were tested in duplicates. Diethyl maleate (DiEM) (Sigma) adjusted to 100µM in 
sterile water was used to deplete the yeast’s glutathione stock [162] and assess the 
glutathione-dependent CMFDA staining. 

Polyclonal rabbit anti-capsular antibodies together with cyanine3 (Cy3) or R-phycoerythrin 
(PE)-labeled goat anti-rabbit IgG (Anti-IgG-Cy3 or Anti-IgG-PE) (Invitrogen) were used to 
stain the capsule of yeasts at 1:100 for 30 min-incubation. The polyclonal sera were 
obtained after immunization of rabbits with whole heat-killed yeasts adapted from 
published procedures [164]. 

Additional dyes were used to characterize metabolic activities or yeast cell organization: 
(i) mitochondrial activity with Mitotracker Orange CMTMRos (Invitrogen) at 40nM (30 min 
incubation at 37°C) [22]; (ii) RNA content with SYTO85 (Invitrogen) at 5 µM (30 min-
incubation at 37°C); (iii)  lipid membrane layers staining with MDY64 (Invitrogen) at 10µM 
(3 min-incubation at room temperature (RT) [67]; (iv) nucleus morphology with DAPI 
(Invitrogen) at 1:5000 (5 min incubation at RT) [67].	  !
Baseline genotypes and phenotypes characterization of the clinical isolates.

The genotype of each ClinCn was determined by Multi-Locus Sequence Typing (MLST) 
on 7 loci, as previously described [140]. Morphological aspect (smooth or mucous) was 
assessed after 72 hours of culture on SDA at 30°C. Growth curves were determined in 
96-well plates starting at 106/ml without agitation in liquid YPD at 30°C (triplicate wells). 
The optical density (OD) was recorded at 600 nm up to 140 hours of incubation 
(LabSystems Multiskan). The regression line (y=ax+b) was determined and results 
expressed as the ratio between the slopes (“a” value) for the ClinCn compared to H99. 
Cell and capsule sizes were determined after standard YPD culture. Cells suspensions 
were made at 106/ml in PBS. An aliquot was observed in India ink suspension using a 
microscope Axioscan (Carl Zeiss, Germany) and the camera AxioCam ICc1 (Carl Zeiss, 
Germany). Cell size, delineated by the cell wall, as well as capsulated cell size, delineated 
by the white exclusion zone around the cells, were measured for 10 cells randomly-
selected of each ClinCn and H99 using the Zeiss AxioVision software (Carl Zeiss, 
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Germany). Results were expressed as the average size ratio for ClinCn/H99. The binding 
of E1 mAb to the capsule surface was determined. Yeasts were cultured on SDA for 24 
hours at 30°C, for each ClinCn, washed in PBS and suspended at a concentration 
equivalent to 0.1 OD at 600 nm. Then, 300μl of the suspension were centrifuged and 
pellets were resuspended in 100μl of PBS containing E1 mAb (0.5μg/ml) and FITC anti-
IgG for 20 min in the dark at room temperature. Then, 400μl of PBS-PFA 1% was added 
to fix cells before cytometry analysis. The results were expressed as the ratio between the 
geometric mean of the FITC-fluorescence intensity for the ClinCn and H99. The chitin 
content was determined after standard YPD culture and standard calcofluor-staining by 
quantification of the geometric mean of the calcofluor fluorescence intensity for the 
ClinCn and H99 using flow cytometry (see below). 
To study the variability of the s9-ClinCn, urease activity and melanin formation were 
quantified using urea agar base medium [165] and asparagine agar containing 1mM of L-
Dopa [25]. Urease activity and melanin formation of 105 to 107 yeasts cells after 24 hours 
of incubation at 37°C and 72 hours of culture at 30°C, respectively, were quantified by 
measuring the diameter of the pink halo (urease), and the RGB content of colonies 
(laccase) using ImageJ software. The mating assay used Murashige and Skoog medium 
[166] and fertility was assessed after 7 days of incubation at room temperature in the dark 
with KN99a (serotype A, mating type a), KN99alpha (serotype A, mating type alpha) and 
JEC20 (serotype D, mating type a).
!
Interaction with macrophages.

J774 cells suspension (105 in fresh medium per well of a 24-well culture plate) were 
incubated at 37°C in 5% CO2 for 48 hours. The day of the experiment, E1 mAb (250μl) 
and CALCO-stained yeasts suspension (250μl) both in fresh medium at the desired 
concentrations were added to the J774 cell monolayer and incubated at 37°C and 5% 
CO2 for 2 hours (phagocytosis assay, Cn:J774 ratio = 5:1). Non-adherent extracellular 
yeasts were then removed by PBS washings, and incubation stopped to assess 
phagocytosis or protracted to determine intracellular proliferation. Phagocytosis was 
determined after staining residual extracellular yeasts using anti-IgG–FITC, additional PBS 
washings and macrophage lysis using distilled water (Fig. 2A). The samples were then 
centrifuged, resuspended in 1% paraformaldehyde (PFA) in PBS (PFA-PBS), vortexed and 
sonicated for 3 minutes before analysis.

To assess intracellular proliferation of ClinCn using flow cytometry (proliferation assay, 
Cn:J774 ratio = 2.5:1), the incubation was protracted in fresh medium for 48 hours. 
Residual extracellular yeasts were stained by addition of E1 mAb (0.5μg/ml) and anti-IgG–
FITC, PBS-washed and J774 were lysed by water (Fig. 2B). In order to differentiate 
potentially unstained yeasts from cell debris an additional step was done using E1 mAb 
and APC anti-IgG. All yeasts were APCpos while only extracellular yeasts were APCpos 
FITCpos.

Intracellular proliferation was determined for each ClinCn at the end of the phagocytosis 
step (H2) and at 48 hours (H48). Phagocytosis and proliferation were analyzed in two 
independent experiments. As a control, viable CALCOhigh H99 cells present intracellularly 
after 48 hours-incubation with macrophages were compared to freshly labeled yeasts 
(without coincubation) based on CALCOhigh events before (T0) and after 24 hours-YPD 
culture (T24). The total number of CALCOhigh events was recorded by flow cytometry.
!
Flow cytometry analysis of yeasts/macrophages interaction (FACS-YMI).

Flow cytometry analyses were performed using MacsQuant Analyzer and the 
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MacsQuantify Software 2.0 (Miltenyi) to provide absolute quantification. Samples were 
analyzed using FlowJo 8.7 software (Tree Star, Inc.). Aggregates were excluded by gating 
relevant events in the Forward scatter/Side scatter (FSC/SSC) contour plot. Three 
parameters were calculated:

-	 Phagocytic index (PI) as the number of events in the CALCOhighFITCneg gate at H2. 
   
-	 Intracellular proliferation at H2 (IPH2) as the ratio between daughter cells    
(CALCOlow + CALCOmed) and mother cells (CALCOhigh) at H2. 

-	 Intracellular proliferation at H48 (IPH48) as the ratio between daughter cells    
(CALCOlow + CALCOmed) at H48 and mother cells (CALCOhigh) at H2.  
Results were expressed as the ratio of the given parameter for the ClinCn/mutant strains 
compared to H99 parameter determined in the same run. We assessed that results 
obtained during the 2 independent experiments were reproducible for PI, IPH2, IPH48 
(P<0.0001 for each parameter), and mean of replicates were then used for subsequent 
analyses.
!
Dynamic imaging.

The evolution of fluorescence intensity from mother to daughter intracellular yeasts was 
assessed by dynamic imaging (Nikon Biostation). J774 were cultured and incubated with 
CALCO-stained yeasts (2.5:1) in dishes (Hi-Q4 35 mm, Nikon) at 37°C and 5% CO2. 
Series of images were taken by phase contrast and fluorescence microscopy (DAPI filter) 
every 5 minutes for 24 hours at x40 magnification. Merging and inverting the look-up 
table were done using ImageJ software (http://rsb.info.nih.gov/ij/). The movie was 
generated from the 289 modified pictures using iMovie software v8.0.6 (Apple Inc).
!
Virulence in mice.

Outbred OF1 male mice (age 6–8 weeks) (Charles Rivers Laboratoires) were housed 7 per 
cage in our animal facilities and received food and water ad libitum. The inoculum was 
prepared in sterile saline from standard YPD culture. The yeasts suspension (105/mouse) 
was inoculated intravenously to 7 mice. Survival was recorded once daily until day 60 
after inoculation. Animals about to die (unable to reach their food) were systematically 
euthanized by CO2 inhalation. Animal studies were approved by the Institut Pasteur 
Animal Care Committee (#03/144).  !
Real-time PCR.

RNA extraction was performed on the s9-ClinCn and H99 coincubated with J774 cells 
(intracellular condition (iH2)) or in fresh medium (baseline condition (BsH2)) for 2 hours at 
37°C in 5% CO2. For iH2, J774 cells were washed twice with PBS, scraped, lysed in 2 mL 
0.05% SDS ice-cold water, vortexed and the pellet was collected after 3 min 
centrifugation at 2000 relative centrifugal force (rcf). RLT Lysis Buffer (500µl, Qiagen) + 
1:100 beta-mercaptoethanol (Sigma) was added to the yeasts pellets. The suspensions 
were transferred to ceramic MagNa Lyser Green beads tubes (Roche Diagnostics), 
homogenized 3 times (MagNa Lyser Instrument, 30 sec, 7,000 rpm), centrifuged (3 min, 
10,000 rcf). RNA extraction was performed on 350 µl supernatant using the RNeasy Mini 
kit (Qiagen). RNAs were quantified and qualified using the Nanodrop® spectrometer 
(ThermoFisher Scientific Inc.). 

cDNA was generated from TurboDNase (Ambion)-treated RNA using the Transcriptor First 
Strand cDNA Synthesis Kit (Roche Diagnostics). Quantitative RT-PCR using 10µl of 
LightCycler 480 SYBR Green I Master, 2 µl of cDNA, and specific primers (Primer table 1) 
in a LightCycler® 480 (Roche Diagnostics) consisted in a denaturation step at 95°C, 45 
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cycles of amplification (95° for 5 sec, 60°C for 5 sec and 72°C for 5 sec). Each cDNA was 
analyzed in duplicate and normalized with the corresponding GAPDH gene expression 
[167], ACT1 gene (actin 1) expression being variable function of experimental conditions 
(data not shown). Fold changes for each s9-ClinCn (iH2 and BsH2 conditions) were 
assessed compared to H99 in the same conditions, according to Pfaffl [168]. Two 
independent RNA extractions for each condition were analyzed blindly, and an internal 
calibrator consisting in an iH2 cDNA of H99 was used in each RT-PCR run as 
recommended [169].
!
In vitro and in vivo models to study yeast adaptation to host. 
Fungal cell isolation after yeasts/macrophages interaction 
J774 cells suspension (105 in fresh medium per well of a 24-well culture plate) were 
incubated at 37°C in 5% CO2 for 48 hours. The day of the experiment, E1 mAb and 
CALCO-stained yeasts suspension both in fresh medium at the desired concentrations 
were added to the J774 cell monolayer and incubated at 37°C and 5% CO2 for 2 hours 
(Cn:J774 ratio = 5:1). Non-adherent extracellular yeasts were then removed by PBS 
washings, and incubation was stopped (iH2) or protracted for 24 hours (iH24). At the end 
of the incubation time, non-adherent yeasts were removed by PBS washings and 
intracellular yeasts were recovered after use of a cell scrapper and 0.05% Sodium 
Dodecyl Sulfate (SDS, Sigma) ice-cold RNAse-free water (Invitrogen) (lysis solution) over 
the macrophage layer. The yeast suspension was then centrifuged, washed twice in PBS.
!
Fungal cell isolation from organs of infected mice 
Experimental infections were performed with 6 to 8 weeks outbred OF1 (Charles Rivers 
Laboratoires) or BALB/c (Janvier) male mice. Animals were housed 7 per cage in our 
animal facilities and received food and water ad libitum. Animal studies were approved by 
the Institut Pasteur Animal Care Committee (#03/144). 

The inoculum was prepared in sterile saline from CALCO-stained yeasts after standard 
YPD culture. A 106/ml yeasts suspension (105/mouse) was inoculated intravenously. Mice 
were euthanized 7 days after inoculation by CO2 inhalation. For specific experiments, 
mice were sacrificed at early time points (30 min, 7, 15 and 30 hours) after inoculation. 
After sacrifice, the lungs, spleen and brain were aseptically removed. Tissues were then 
homogenized by grinding fresh tissue in a Potter homogenizer with 2 mL lysis solution. 
The suspension was transferred in a 2ml tube, centrifuged at 2,000 rcf and washed twice 
in lysis solution and once in PBS. The pellet was then filtered in a 40µm cell-strainer (BD 
biosciences) in PBS over a sterile Petri dish to remove the largest tissue debris. The 
filtrate was then centrifuged and washed once with PBS. 
!
Stress response staining protocol (CMFDA/TOPRO assay) 
After washings the yeasts pellet, a solution of CMFDA (10µM) and TOPRO (10µM) in PBS 
was added, and incubated for 30 min at 37°C. Three PBS washings were then performed 
to remove extra dyes. For specific experiments, the pellet was then incubated 30 min at 
RT in a 1:100 solution of polyclonal rabbit anti-capsular antibodies together with anti-IgG-
Cy3 or anti-IgG-PE and washed twice in PBS. Just before flow cytometry analysis, an 
additional filtration step (35µm cell-strainer) was requested to remove newly formed 
aggregates.
!!!
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Analysis of C. neoformans populations upon host interaction. 
Microscopy techniques 
Interferential contrast microscopy (DM LB2 microscope, Leica) and epifluorescence 
microscope (Axioscan, Carl Zeiss) were used to analyze morphology and fluorescence 
features of the yeasts recovered from lungs homogenates before and after stainings and 
pictured with the camera AxioCam MRm (Carl Zeiss).

Yeast multiplication was assessed by dynamic imaging (Nikon Biostation). Yeasts 
recovered from lung homogenates were suspended in YPD at 30°C without CO2. Series 
of images were taken by phase contrast and fluorescence microscopy (DAPI filter) every 
10 minutes for 48 hours at x40 magnification.
!
Classical flow cytometry analysis 
To better characterize the yeast populations in terms of multiplication and stress 
response, fluorescence intensity was quantified using MacsQuant Analyzer with the 
MacsQuantify Software 2.0 (Miltenyi) and analyzed using FlowJo 8.7 software (Tree Star, 
Inc.). Aggregates were excluded by gating relevant events in the forward scatter/side 
scatter (FSC/SSC) contour plot. PEhigh (yeasts) and APClow (viable yeasts) population was 
then gated and the DAPI/FITC channels dot plot was analyzed for multiplication (CALCO/
DAPI channel) and stress response (CMFDA/FITC channel).
!
Multispectral flow cytometry analysis 
To connect cell morphology and fluorescence feature we used ImageStreamX with the 
INSPIRE software (Amnis Corporation). Cell suspensions were adjusted to 107 in 80 µL 
and 10,000 cells were recorded at 40-fold magnification in 5 different channels including 
the right field channel (BF) and 4 fluorescence channels (channel 3: 560-595nm [E1-Cy3, 
yeasts], channel 2: 470-560nm [CMFDA], channel 7: 430-505nm [CALCO], channel 11: 
660-720nm [TOPRO]). Data analysis was performed using the IDEAS software (Amnis 
Corporation) after fluorescence compensation procedures. The first step consisted in the 
definition of a mask that delineated the relevant pixels in each picture. Then, 54 
algorithms (calculations made for each event within a defined mask) were used to analyze 
size, texture, location, shape or signal strength.

Using basic algorithms, unfocused events, tissue debris, yeasts aggregates and dead 
yeasts were excluded (Figure 16). For multiplication and stress response analysis, gates 
were determined based on the CALCO/CMFDA dot plot considering the intensity 
algorithm and optical control of the events pictured in the gates. For each population of 
interest, the geometric mean was calculated using the IDEAS software. From the whole 
dataset and each algorithm, data were then normalized between 0 and 1, with 0 as the 
minimal value and 1 as the maximal value. Schematic representation was performed 
using the open-source genomic analysis software MeV v4.6.1 (The TM4 Development 
Group) obtained from www.tm4.org [170]. Hierarchical clustering was performed using 
complete linkage clustering and Pearson correlation.
!
Analysis of specific C. neoformans populations. 
Sorting of the yeasts cells population based on CMFDA fluorescence intensity 
Based on the discovery of variable yeasts stress responses upon host interaction, cell 
sorting was decided to better characterize the phenotypes of these populations using the 
FACS Aria II (BD biosciences). 
Yeasts obtained after 24hours-incubation within macrophages were sorted based on 
CALCO/CMFDA dot plot while yeasts obtained from 21 to 42 pooled mice inoculated 7 
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days before, were sorted based the SSC/CMFDA dot plot. Aggregates, cell debris (PElow 
population), and dead yeasts (APChigh population) were then excluded. Three populations 
were sorted as CMFDAhigh, CMFDAmed, CMFDAlow for both conditions, with an additional 
population of CMFDAhigh/CALCOlow for the yeasts recovered after macrophage 
interaction. Independent duplicate experiments were performed and used for growth 
kinetics determination and gene expression analysis.

A yeast sample, harvested from a standard YPD culture, stained at the same time and 
stored in the same conditions than the experimental samples was used as a control 
(stained stationary control, sSTAT).
!
Growth curves determination 
The growth kinetics of each population was analyzed. After sorting and centrifugation at 
2000 rcf, the populations were ressuspended in sterile YPD containing 10% penicillin/
streptomycin (YPDps) at the desired concentration based on the absolute count provided 
by the cell sorter. 

Each sample was studied in duplicate in the presence or absence of 10% FCS 
supplementation (100µL final volume) in parallel with sSTAT control and medium alone. 
The plates were incubated in a thermomixer (Eppendorf) at 30°C and 700 rpm. Optical 
density (OD) was recorded at 600nm at different time points. Analysis of the growth 
curves was performed using Prism Software 5.0 (GraphPAD Software) and the Weibull 
algorithm [171].
!
Sample preparation for quantitative real-time PCR 
After sorting, the different yeasts populations were washed carefully in RNAase-free water 
to remove PBS salts, flash-frozen in liquid nitrogen and stored at -80°C. sSTAT control 
were processed in parallel. All experiments were performed with the SuperScript™ III 
Platinum® CellsDirect One-Step qRT-PCR Kit (Invitrogen) that is classically used for 
single-cell PCR analyses. The day before RNA extraction, the samples were lyophilized 
overnight. One microliter of lysis enhancer and 10µL of resuspension buffer were added 
to the lyophilisates and incubated 10 min at 75°C. Then, 1.6µl of DNAse buffer and 5µL of 
DNAse I were added and incubated 5 min at 25°C and then inactivated using 4µL of EDTA 
and incubation at 70°C for 10 min. RNA samples were then stored at -80°C. 
!
One step quantitative real-time PCR 
We based our selection on the genes that were homologues between H99 and 
Saccharomyces cerevisiae [172]. All H99 genes for which the gene description for S. 
cerevisiae contained the keywords ‘growth’, ‘stationary phase’, ‘starvation’, ‘oxidative 
stress’, were first selected. Additional H99 genes involved in capsule and cell wall 
formation and some regulated during early pulmonary infection [26] were added. The 
coding sequence of the selected H99 genes was then retrieved from the Broad Institute 
website (http://www.broadinstitute.org). The sequence of 90 different pre-designed 
Locked Nucleic Acids octamer probes of human Universal ProbeLibrary set (Roche) were 
used as the probe library. If a probe matched the selected gene, the corresponding 
primers were designed using the dedicated ProbeFinder Software (Roche, http://
www.universalprobelibrary.com). At the end, 37 assays were implemented for real-time 
quantitative PCR, including 33 for nuclear genes (Primer Table 2), 1 for ribosomal RNA 
genes (18S rRNA), 1 for a mitochondrial gene (COX1) and 2 for reference genes (ACT1 
and GAPDH).

Quantitative RT-PCR that allows primer specific reverse transcription (50°C for 15min) and 
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quantitative PCR amplification based on probe detection (95°C for 2 min and 45 cycles of 
95°C 15 sec and 60°C 30 sec) was performed in a total volume of 10µL including 2µL of 
1:10 dilution of each RNA samples. 

Each RNA sample was normalized with geometric mean of the Cq of the corresponding 
ACT1 and GAPDH gene expression [167]. Fold changes for each sample were calculated 
according to Pfaffl [168]. For hierarchical clustering analysis using MeV v4.6.1, the data 
were normalized as described above. !
Statistical analysis. 
Graph and Pearson’s index (R2) calculation, exact Fisher’s test and one-way ANOVA test 
were performed using Prism 4.0 (GraphPAD Software). STATA 10.0 software (Stata 
Corporation) was used to compare the ClinCn/macrophages interactions’ phenotypes 
with clinical outcome for the corresponding patients. For the multivariate analysis, logistic 
regression was used to determine factors independently associated with non-sterilization 
of CSF at week 2 (45 patients with available information). Only 2 variables were entered in 
the model because of the limited number of events (n=24). Odds ratios (OR) and their 
95% confidence intervals (95% CIs) were determined. 

Schematic representation of fold changes was performed using the open-source genomic 
analysis software MeV v4.6.1 (The TM4 Development Group) obtained from http://
mev.tm4.org  [170]. Complete linkage clustering and Pearson correlation were chosen to 
perform hierarchical clustering. The principal component analysis (PCA) analysis was 
performed based on 3 interaction parameters (PI, IPH2 and IPH48) and 5 mycological 
parameters (cell and capsule size, E1 binding, growth and chitin content) using the open-
source genomic analysis software MeV v4.6.1 (Manhattan distance, mean centering mode 
and 10 neighbors for KNN imputation). Variables were compared using the Student’s t 
test. P values ≤0.05 were considered significant.
! !
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New flow cytometry assays are implemented to assess the dynamics of yeasts/
macrophages interactions 
To estimate whether the interaction between ClinCn and host cells interactions was 
variable, we developed original quantitative flow cytometry assays using J774 murine 
macrophage cell line. Calcofluor (CALCO) is a basic fluorescent dye used to stain fungal 
cell wall. Preliminary studies using calcofluor staining revealed that fluorescence is 
transmitted from mother to daughter cells during multiplication in various conditions 
(YPD, within macrophages or in vivo) (Figure 1A). Immediately after staining, mean 
fluorescence intensity (MFI) was high for all cells. In YPD, after 3 hours of culture, an 
emerging population with a decreased MFI was detected while budding cells harboring 
decreased fluorescence were seen using fluorescence microscopy. This suggested that 
CALCO-labeled chitin was transferred from mother to daughter cells during budding. 
During protracted incubation, several populations with decreased MFI progressively 
appeared while the high CALCO-fluorescent initial population progressively disappeared 
over 24 hours. This phenomenon was confirmed using dynamic imaging of yeasts 
proliferating inside J774 cells (Figure 1B-D). The decrease in CALCO fluorescence 
intensity observed in yeasts cells recovered from the lungs (Figure 1A, right panel) as 
soon as 30 minutes after inoculation was attributed to quenching and not multiplication 
(data not shown).

Based on these observations, we decided to assess the dynamics of yeasts/
macrophages interactions by flow cytometry (FACS-YMI) assays using the MacsQuant® 
analyzer (Figure 2). Preliminary experiments (Figure 3) using the reference strain H99 
helped us define optimal opsonin quantity (E1 mAb) and yeasts:macrophages ratio using 
microscopy. Two E1 concentrations and ratio were fixed as 5µg E1 mAb and 5:1 ratio for 
phagocytosis assay and 1µg E1 mAb and 2.5:1 ratio for proliferation assay (Figure 3A).

In the phagocytosis assay, three distinct populations were observed on the CALCO/FITC 
dot plot, the intracellular yeast population being CALCOhighFITCneg, the extracellular yeast 
CALCOhighFITCpos, and cell debris CALCOnegFITCneg (Figure 4A). This allowed us defining 
a phagocytic index (PI) (103.7 for H99). In the proliferation assay, three distinct 
intracellular yeast populations (APCposFITCneg gate) were observed, the mother yeast cells 
population being CALCOhigh, and 2 populations of daughter cells CALCOmed and 
CALCOlow (Figure 4A), the lowest fluorescent cells (daughter cells) being the smallest in 
size, as determined based on the Forward scatter (FSC, Figure 3B). After 48hours of 
incubation, the FSC values of the CALCOhigh and CALCOmed populations were higher than 
after 2 hours of incubation. Intracellular proliferation indexes were then calculated based 
on the number of CALCOhigh, CALCOmed and CALCOlow populations after 2 (IPH2) and 48 
(IPH48) hours of incubation (1.00 and 1.20, respectively for H99).

Results obtained with H99 mutants validates the FACS-YMI assays 
To validate the assays, mutant strains derived from H99 and known for increased 
phagocytosis (app1∆, lac1∆) and decreased proliferation (vad1∆, vps34∆, ipc1∆ and 
lac1∆) were screened in comparison to H99. The FACS-YMI assays allowed 
discrimination between mutant strains based on PI, IPH2 and IPH48 (P<0.0001 each, 
Figure 5). For the mutants, the PIs were categorized in 2 groups (similar to H99 [ranging 
from 0.8 to 1.2] for vps34∆, ipc1∆, vad1∆ or higher [1.5 to 1.9] for app1∆, lac1∆). Three 
categories were also delineated for IPH2 (very low [0.02-0.04] for vad1∆ and vps34∆, 
intermediate low [0.35] for lac1∆, and low [0.7] for app1∆ and ipc1∆), and for IPH48 (very 
low [0.02-0.2] for vps34∆ and vad1∆, low [0.8] for lac1∆, and high [2.9-3.1] for app1∆ and 
ipc1∆).
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Interactions of C. neoformans clinical isolates with J774 macrophages are highly 
diverse 
Based on these validated FACS-YMI assays, we then studied 54 ClinCn recovered from 
the CSF of HIV-positive or -negative unrelated patients (Table 1). An important diversity in 
terms of genotypes (11 MultiLocus Sequence Types) and baseline phenotype 
characteristics (colony morphology, cell and capsule sizes, growth rate, E1 mAb binding 
level, chitin content, urease activity and melanin production) was observed (Figure 6).

We then established the diversity of the ClinCn/macrophages interactions. A 30-fold 
variation in PI (Figure 7A and Figure 8), 50-fold variation in IPH2 and 16-fold variation in 
IPH48 (Figure 7B and Figure 8) were found. The E1 mAb binding level is inversely 
correlated with PI (P=0.006). The ClinCn exhibiting high (≥ 0.5) PI and low (<1.0) E1 mAb 
binding level were mostly smooth (26/30, 86.7%), as compared to those exhibiting low PI 
and high E1 binding which were mostly mucous (9/10, 90%, P<0.0001, Figure 9). There 
was no significant association between genotypes and baseline phenotypes or 
phenotypes of ClinCn/macrophages interaction using principal component analysis (PCA, 
data not shown).
!
ClinCn/macrophages interactions phenotypes are associated with variable outcome 
of cryptococcal meningoencephalitis in humans

Given the high variability of ClinCn/macrophages interaction phenotypes, we then 
wondered if these parameters (PI, IPH2, IPH48) correlated with outcome of infection in 
the corresponding patients. Four categories of isolates were defined according to PI (<0.5 
and ≥0.5) and IPH2 (≤1 and >1). Based on univariate analysis, non-sterilization of CSF 
despite 2 weeks of antifungal therapy was associated with a population of isolates 
harboring decreased PI and IPH2 (Figure 10 and Table 2). The proportion of parameters 
previously [11] associated with non-sterilization of CSF (gender, dissemination, or high 
CSF antigen titer) did not significantly differ among the four categories of isolates. Death 
at months 3 was significantly associated with a population of isolates harboring high PI 
and IPH2 (Figure 10). Parameters previously [11] associated with death at month 3 
(abnormal neurology or brain imaging) did not significantly differ among the four 
categories. In the multivariate analysis, the risk of non-sterilization of the CSF at week 2 
was independently associated with low PI and IPH2 (Odds Ratio (OR) [95% CI]= 15.5 
[1.3-184.4], P=0.030) and with HIV infection (OR=25.2 [1.8-348.6], P=0.016) (Table 2).

Expression of some virulence factors correlates with ClinCn/macrophages 
interaction phenotypes 
Considering that in a standardized in vitro model, variations in ClinCn/macrophages 
interaction phenotypes were associated with different outcomes in humans, we further 
explored known virulence factors in relation with these phenotypes. We selected 9 ClinCn 
(s9-ClinCn) based on various combinations of their ClinCn/macrophages interaction 
phenotypes (Figure 11A), genotypes and related patient’s outcomes. All s9-ClinCn were 
fertile (data not shown), with variable virulence in mice as shown by median survivals 
(expressed as a ratio for each s9-ClinCn to H99) ranging from 0.57 (AD2-82a) to 3.3 
(AD1-07a) (Figure 11B, p <0.0001). The 2 hours-intracellular (iH2) and baseline (BsH2) 
relative expressions of 6 virulence factors (LAC1, URE1, APP1, VAD1, IPC1, PLB1 genes 
[63,114,115,158,159,173])  and one mitochondrial gene (cytochrome oxidase 1, COX1 
[22,174])  were quantified with GAPDH as the reference gene and H99 as the control. 
High BsH2 APP1 expression (>5 fold) was significantly associated with low PI (P=0.028). 
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IPH48 and iH2 expression were significantly correlated for IPC1 (R2=0.73, P=0.003), APP1 
(R2=0.66, P=0.008), COX1 (R2=0.66, P=0.008), VAD1 (R2=0.65, P=0.009) (Figure 11C), and 
PLB1 (R2=0.55, P=0.021). PI and iH2 expression of LAC1 (R2=0.59, P=0.016) were also 
correlated.  No correlation was found for URE1 gene expression. 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Figure 1: Decrease in fluorescence in calcofluor-labeled C. neoformans 
 (reference strain H99) during multiplication. 
(A) Yeast multiplication in vitro was evaluated after yeasts staining with calcofluor prior to incubation at 30°C 
in liquid YPD, interaction with murine macrophages or inoculation to OF1 outbred mice. The yeasts were re-
covered from different environments (YPD culture, J774 cells, and Lungs) at different time points, and com-
pared to unstained yeasts using flow cytometry (MacsQuant analyzer). The appearance of a population with 
lower CALCO fluorescence (daughter cells) was visualized over time during incubation in the three conditions. 
Of note, the decrease in CALCO fluorescence intensity observed in yeasts cells recovered from the lungs as 
soon as 30 minutes after inoculation was attributed to quenching and not multiplication (data not shown). (B-
D) Visualization of H99 multiplication inside macrophages assessed by dynamic imaging. Yeasts were stained 
with calcofluor prior to incubation with J774 cell line at a 2.5:1 ratio in the presence of E1 anti-capsular poly-
saccharide monoclonal antibody (E1mAb) (106 yeasts/1μg E1mAb). Dynamic imaging using the Nikon Biosta-
tion was performed starting after one hour of coincubation (images obtained at 16 hours 45 min are shown). 
(B) DAPI fluorescence filter. (C) Transmitted light. (D) Decreased fluorescence of daughter cells assessed af-
ter image treatment using ImageJ software (merging pictures B and C and inverting the look-up table. Mother 
yeast cells appear black whereas daughter cells look medium to light grey (original magnification x40). 
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Figure 2: Schematic representation of C. neoformans labeling steps for flow cytom-
etry analysis of yeasts/macrophages interaction (FACS-YMI).

Yeasts were first stained with calcofluor and then incubated with J774 cells at 37°C in the presence of E1 
mAb (opsonin). After careful PBS washings, the incubation was stopped after 2 hours incubation (phagocy-
tosis assay, A) or prolonged up to 48 hours  in fresh medium (proliferation assay, B). In both assays, re-
maining extracellular yeasts were then stained with anti-IgG–FITC antibody, washed and J774 cells lysed 
using H2O. An additional labeling step was performed in the proliferation assay with E1 mAb and an anti-
IgG–APC added to stain daughter yeast cells. Samples were analyzed using the MacsQuant® analyzer. 
Figure 3: Preliminary experiments. 

(A) Influence of the Cn:macrophages ratio and of the E1 mAb quantity on the magnitude of yeast strain H99 
phagocytosis by murine macrophage cell line J774. The concentration of macrophages was kept constant 
while that of H99 varied to provide a ratio ranging from 1:1 to 10:1. The anti-capsular polysaccharide E1 
mAb was added at 0.1, 1 or 10 µg/well. The optical phagocytic index (Opt-PI) was calculated as the num-
ber of intracellular yeasts /100 macrophages. Each condition was tested in duplicate in 2 independent ex-
periments. Optimal conditions for the phagocytosis and the proliferation assays are shown. The bars repre-
sent the mean ± SD of one representative experiment.(B) During intracellular proliferation of H99 yeast 
cells, the size of each yeast cell using forward scatter (FSC) histograms (right panel) is lower in the daugh-
ter cell populations (CALCOlow and CALCOmed) compared to mother cells (CALCOhigh) at H2 and H48.
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Figure 4: The FACS-YMI allowed assessment of the dynamics of yeasts/
macrophages interactions. 
(A) Determination of phagocytosis. Intracellular yeasts (CALCOhighFITCneg) were easily discriminated from 
extracellular yeasts (CALCOhighFITCpos) and macrophage debris (CALCOnegFITCneg). (B) Determination of 
yeasts intracellular proliferation. After selection of the APCpos (excluding cell debris, upper left graphs) and 
FITCneg populations (intracellular Cn, lower left panels), different subsets of intracellular Cn corresponding to 
mother Cn cells (CALCOhigh), and daughter Cn cells (CALCOmed and CALCOlow) were observed (right panels). 
A decrease of mother cells in parallel to an increase of daughter cells populations was observed between 2 
hours (H2) and 48 hours (H48) of coincubation, asserting intracellular proliferation (number of events report-
ed above each subset).
Figure 5: Screening of well-character-
ized mutant strains compared to H99 
using the FACS-YMI. 

Dot plots presenting the corresponding phagocy-
tosis (PI), intramacrophagic proliferation at H2 
(IPH2), and H48 (IPH48) values for each mutant 
linked by a solid line (Log10 scale). PI were catego-
rized in 2 groups: similar to H99 (vps34∆, ipc1∆, 
vad1∆), higher (app1∆, lac1∆). Three categories 
were also delineated for IPH2 (very low for vad1∆, 
vps34∆; intermediate low for lac1∆, and low for 
app1∆ and ipc1∆), and for IPH48 (very low) for vp-
s34∆ and vad1∆; low for lac1∆, and high for app1∆ 
and ipc1∆).
Table 1: Characteristics of the 54 patients 
corresponding to the 54 clinical isolates of 
Cryptococcus neoformans studied.
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Figure 6: The baseline phenotype of the ClinCn is diverse in terms of enzymatic ac-
tivity and cell characteristics.

(A) Distribution of cell sizes, capsule sizes, growth rates (slope), E1 mAb binding level and chitin content 
compared to H99 reference strain (horizontal lines represent mean ± SD). (B) Variability of urease activity in 
the s9-ClinCn (105 to 107 cells) expressed as the diameter of the red colored circle around the colony (Im-
ageJ software v1.42q). (C) Variability of melanin production in the s9-ClinCn (105 to 107 cells) as shown by 
the intensity of the brown pigment.
Figure 7: Phagocytosis and proliferation assays. 
(A) Contrasted phagocytic indexes for 2 ClinCn compared to H99 assessed using FACS-YMI (left panel) and 
fluorescence microscopy (right panel). The number of CALCOhighFITCneg events (intracellular yeasts) is re-
ported above the gates.  Blue-fluorescent Cn cells are intracellular whereas blue- and green-fluorescent Cn 
cells are extracellular (Right panel). (B) Contrasted proliferation indexes (IPH2 and IPH48) for 2 ClinCn com-
pared to H99 assessed using FACS-YMI at 2 hours (H2), 24 hours (H24) and 48 hours (H48) of coincubation. 
The proportion of CALCOhigh, CALCOmed, CALCOlow events in the APCpos, FITCneg gates is reported above 
each gate. 
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Figure 8: The 54 Cn clinical isolates 
(ClinCn)  harbored variable interactions 
with macrophages.

Compared to H99, the distribution of phagocytic (PI), 
2 hours-proliferation (IPH2), and 48 hours-prolifera-
tion (IPH48) indexes showed 30-fold, 50-fold, 16-fold 
variations, respectively (Log10 scale). Each circle rep-
resents the mean of duplicates for a given ClinCn ob-
tained from 2 independent experiments. Bars repre-
sent mean ± SD for the 54 ClinCn.
Figure 9: Scatter plots presenting PI 
vs. E1 binding 
The E1 mAb binding level is inversely correlated 
with PI. Scatter plot of PI vs. E1 mAb binding 
level for the 54 ClinCn compared to H99 ac-
cording to colony morphology recorded as mu-
cous (open circle) or smooth (black circle). The 
solid line represents the regression line 
(P=0.006). Dotted lines show the cut-off values 
for PI and E1 mAb binding delineating a signifi-
cant association with colony morphology 
(P<0.0001).
Figure 10: Scatter plots presenting PI vs. IPH2 
Four categories of isolates were defined according to PI (<0.5 and ≥0.5) and IPH2 (≤1 and >1). Population 
of isolates harboring PI <0.5 and IPH2 ≤1 was significantly associated to non-sterilization of CSF at week 2 
(P=0.03) and that harboring PI ≥0.5 and IPH2 >1 was significantly associated to death at months 3 
(P=0.05).
!
!                                                                                                                                                
 47
!                                                                                                                                                
!!!!!!!!!!
!
!
!
!
!
!
 42
Figure 11: The in vivo behavior (virulence in mice) of the s9-ClinCn is heterogeneous 
and the intracellular (J774 cells) expressions of known virulence factors correlate 
with the 48 hours-proliferation index. 
(A) Dot plots presenting the corresponding PI, IPH2, and IPH48 values for each s9-ClinCn. The values cor-
responding to a given isolate are linked by a solid line (Log10 scale). (B) Outbred male mice were intra-
venously inoculated with 105 yeasts, and death recorded over 60 days. Compared to H99 (Black circle, 
thick line), AD2-82a (opened circles, dotted line) is more virulent (median survival ratio = 0.57), whereas 
AD1-95a (black triangle, dotted line) and AD1-7a (black square, dotted line) are less virulent (median sur-
vival ratio = 2.1 and 3.3, respectively). (C) Compared to H99, IPH48 of the s9-ClinCn correlated with the 
intracellular expression of IPC1, VAD1, APP1, COX1 genes. Bars represent mean ± SD of duplicates from 2 
independent experiments for each s9-ClinCn. The linear regression curve is shown.
Table 2 : Analysis of patient’s outcome considering the four categories of isolates 
defined based on PI and IPH2. 
Patients’ outcomes (non-sterilization of CSF at week 2 and death at month 3) are significantly associated 
with the phenotypes of interaction with J774 macrophages (phagocytic index (PI) and intracellular prolifera-
tion at H2 (IPH2)) of the clinical isolates for which the corresponding outcome was available.
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Implementation of a new flow cytometry assay to analyze simultaneously 
multiplication and stress response in C. neoformans  
To study yeast adaptation to different environments, we developed an assay that 
combined analysis of multiplication and stress response. Multiplication was quantified as 
described above (Figure 1A ) . Stress response was evaluated using 5-
chloromethylfluorescein diacetate (CMFDA) (Figure 12A-C) that measured a glutathione-
dependent phenomenon as shown by preliminary experiment using diethyl maleate, a 
glutathione-depleting agent (DiEM, Figure 12A). The yeast cells in stationary phase 
(Baseline, H0) harbored basal fluorescence that increased over time with various stresses 
(water, hydrogen peroxide, fresh medium and heat (Figure 12B). Of note, after 24 hours of 
incubation in hydrogen peroxide, the CMFDA fluorescence level was comparable to the 
unstained condition (Figure 12B, right upper panel) with CFU analysis revealing that all 
yeasts were dead (data not shown). The level of CMFDA fluorescence depended on the 
stimulus (2 hours) with YNB medium inducing the lowest and hydrogen peroxide the 
highest stress response (Figure 12C). 

Viability of the yeasts was assessed based on Topro-3 iodide (TOPRO) fluorescence 
(Figure 13), allowing exclusion of dead cells in all subsequent experiments. !
Dynamics of C. neoformans adaptation to host 
We used two models to study the yeasts adaptation to the hosts in terms of multiplication 
and stress response, looking for changes over time in vitro (J774 macrophages) and in 
vivo (mice) (Figure 14).

A population of daughter yeast cells was observed as soon as 2 hours after interaction 
with J774 cells and 15 hours in lungs (Figure 14A, 14C) and increased overtime (Figure 
14B, 14D). CMFDA fluorescence of yeast cells rapidly increased 2 hours after J774 cells 
interaction and 7 hours in lungs compared to the control with the majority of the 
population remaining CMFDAhigh over time. However, a sub-population harboring a lower 
CMFDA fluorescence (called ‘CMFDAlow’, black arrows) at H24 in J774 cells and at H30 in 
lungs appeared and increased overtime. This phenomenon affected first mother cells 
(H24) and then daughter cells (H48) in J774 cells and both populations at H30 in lungs. 

Subsequent experiments were done with mice inoculated 7 days before, based on the 
assumption that dormant cells could already be present and in sufficient number for 
further analysis.

Multiplication and stress response of yeast cells were then assessed in brain, lungs and 
spleen of 6 individual OF1 mice (Figure 15) and analyzed using classical flow cytometry 
(Macsquant analyzer, Miltenyi). Mother cells were not observed in brain, rare in spleen, 
and present in the lung of 3/6 OF1 mice. The mother cell population was never detected 
in any organ of BALB/c mice (data not shown). The pattern of stress response differed 
between organs but was specific with several circumscribed populations in lungs from 
5/6 mice.

We thus decided to explore morphological features and fluorescence characteristics of 
the resident viable yeasts in pooled lungs homogenates using multispectral imaging flow 
cytometry (ImagestreamX) (Figures 16-18). After determination of the optimal analysis 
strategy (Figure 16), we defined 9 populations based on CMFDA/CALCO dot plot and 
optical control (Figure 17A; Figure 16G) and quantified the proportion of each population 
(Figure 17B-D). Daughter cells always represented less than 20% of the three CMFDA 
populations. Mother cells represented more than half of the CMFDAhigh population and 
less than 40% of the others (Figure 17D). The largest cells were mostly composed of 
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mother cells, but a sub-population of mother cells was small-sized cells. Daughter cells 
were mostly small cells (Figure 17E-F). The global analysis of morphological features (54 
algorithms) revealed several clusters with 3 well-defined populations containing daughter 
cells, mother cells and CMFDAlow (Figure 17G).
!
Analysis of specific C. neoformans populations 
To go further into the analysis of the different populations, we focused first on the 
CMFDAhigh/mother cells population (Figure 18). Two patterns of CMFDA fluorescence 
were observed, some cells harboring peripheral extracellular fluorescence (designated 
‘surrounded’, CMFDAsur) and others intracellular fluorescence (CMFDAintra) visualized by 
ImagestreamX  (Figure 18A) and fluorescence microscopy (Figure 18B). These two 
populations were discriminated based on the modulation (texture analysis) and the area 
(size analysis) algorithms dot plot (Figure 18C). The majority of mother cells were found in 
the CMFDAintra while CMFDAsur contained the same proportion of mother and daughter 
cells (Figure 18D). In the CMFDAsur population, some yeasts harbored a typical 
morphology as observed using ImagestreamX (Figure 18A-C) and interferential contrast 
microscopy (Figure 19A). These cells (thereafter called ‘Drop Cn’) were small (5.80µm ± 
0.80) with an enlarged cell wall and a well-defined round refringent vesicle. This 
population was composed of a higher proportion of mother cells compared to yeast cells 
harboring a regular morphology (‘Reg Cn’) (Figure 18E). Drop Cn represented less than 
25% of each CMFDA population (Figure 18C). Compared to Reg Cn, Drop Cn did not 
harbor a well-organized nucleus (DAPI staining), had a low RNA content (SYTO 85) and 
mitochondrial activity (Mitotracker) and exhibited a complete retraction of the cytoplasm 
around the central vesicle (MDY64, Figure 19B-C). These observations suggested that 
Drop Cn were dead yeasts with low transcriptional and mitochondrial activity, and 
disorganized cytoplasm and nucleus architectures, despite having been initially selected 
in the TOPROlow (viable) population. This was confirmed by dynamic imaging after 
observation that Drop Cn cells were unable to bud over 48 hours in YPD + 10% penicillin 
streptomycin (YPDps) (data not shown). Additional experiments showed that the relative 
proportion of the different yeasts populations in terms of multiplication and stress 
response varied with yeast strains (Figure 20A-C), comparing H99 and two previously 
characterized clinical isolates (AD1-07a and AD1-83a) [23]. In addition, the proportion of 
the repartition of the Drop Cn population (Figure 20D-E), the proportion of dead yeasts 
(Figure 20F), and CMFDAsur (Figure 20G) varied also among isolates.

Specific phenotype of the CMFDAlow population 
Cell sorting was implemented to focus on CMFDAlow population compared to others 
recovered from both models of interaction with host [24 hours incubation with 
macrophages (MP) or infected lungs from OF1 mice (MO)] and to control yeasts in 
stationary phase stained in the same conditions (sSTAT) (Figure 21A, 21C). The sorted 
populations were controlled visually using fluorescence microscopy (Figure 21E). We 
wondered whether they harbored specific phenotypes in terms of growth capacity and 
specific transcriptional activity.

Growth curves analysis revealed important differences among the various populations 
with the CMFDAlow population unable to grow (MO) or exhibiting delayed growth (MP) in 
YPD compared to the other populations and sSTAT (Figure 21B, 21D). !!
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Figure 12: Quantification of C. neoformans stress response using CMFDA and flow 
cytometry 
C. neoformans (H99) stress response was evaluated based on 5-chloromethylfluorescein diacetate  (CMF-
DA) staining. (A) Stress response as determined by CMFDA staining measured a glutathione-dependent 
phenomenon. An inhibition of the increased CMFDA fluorescence after addition of diethyl maleate [glu-
tathione-depleting agent (DiEM)] was observed in comparison with water alone after 24 hours of incubation.

(B) Various stresses [H2O, H2O2, DMEM+10%FCS (fresh medium) and heat killing (Heat)] were applied to 
stationary phase (H0) yeasts for 2 hours and 24 hours. CMFDA fluorescence increased over time except at 
H24 after H2O2 incubation where it became negative. (C) Stress responses increased depending on the 
medium of incubation [Yeast base nitrogen (YNB), H2O, H2O2, fresh medium and Heat] were compared to 
baseline (H0) after 2 hours of incubation.
Figure 13: Quantification of viability using TOPRO and flow cytometry

C. neoformans viability was evaluated based on the level of fluorescence after TOPRO staining. Membrane 
disrupted cells after heat killing (Heat) were highly stained (TOPROhigh) compared to living yeasts cells 
(STAT, TOPROlow).
A
C
B
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Figure 15: Yeasts stress response and multiplication depends on individuals (OF1 
outbred mice) and tissues.

Seven days after inoculation with 105 CALCO stained H99, mice were sacrificed and their organs (brain, 
lungs, spleen) ground. Yeasts were stained for stress response and viability using CMFDA/TOPRO assay. 
The analysis was performed using flow cytometry after exclusion of TOPROhigh population (dead yeasts) 
(MacsQuant analyzer, Miltenyi). The profile of brain and spleen Cn was homogenous in terms of multiplica-
tion and stress response, whereas two profiles were observed in lungs. A well-defined CALCOhigh/CMF-
DAhigh population (black gate) was observed for some mice (M1, M2, M3), and not for others (M4, M5, M6). !
Figure 14: Evolution of C. neoformans multiplication and stress response in two 
host environments. 
The CALCO and the CMFDA fluorescence were analyzed after interaction with macrophages (A, B), and in 
lungs of infected mice (C, D). After macrophage lysis and organ grinding, the pellet of H99 yeasts was 
stained using CMFDA (10µM) and TOPRO (10µM) 30 min at 37 °C (CMFDA/TOPRO assay). The analysis of 
the fluorescence was performed using flow cytometry after exclusion of TOPROhigh population (dead 
yeasts). The generation of daughter cells (CALCOlow) was observed as soon as 2 hours of incubation after 
macrophage interaction (A) and 15 hours after mice inoculation (C) and increased over time (B, D). The 
yeast’s stress response (CMFDA fluorescence) rapidly increased as soon as H2 in macrophages (A) and H7 
in the lungs (B). A population harboring a lower CMFDA fluorescence (black arrows) was observed at H24 in 
macrophage (A, B) and at H30 in lungs (C, D), that affected first mother cells (H24) and then daughter cells 
(H48) in macrophages. 
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Figure 17: Multispectral imaging flow cytometry confirms heterogeneity of the yeast 
populations in the lungs of OF1 outbred mice 
Yeasts from pooled lungs of 14 mice (2635 total yeast cells) were analyzed for multiplication, stress re-
sponse and viability. (A) Nine H99 populations (1 to 9) were delineated using multispectral imaging flow cy-
tometry (ImagestreamX). The nine gates were adjusted based on optical control of the fluorescence intensity 
of the corresponding pictured events. One representative of two independent experiments is shown. (B-C) 
The distribution of the different populations. The distribution of the CALCO populations (high, med, low) in 
the different CMFDA population is shown (D). Bars represent means ± SD for each of the 9 populations 
numbered in panel 4A. The CALCOlow population represented always less than 20%. In the CMFDAhigh pop-
ulation, the CALCOhigh population was predominant whereas the CALCOmed population was predominant in 
the CMFDAmed and CMFDAlow populations. (E-F) The analysis of the size of the 3 CALCO populations based 
on the area algorithm revealed that mother yeasts cells are composed of small and medium to high yeasts 
and daughter cells mainly of small cells. (G) Heat map was generated from the bright field channel pictures 
based on the geometric mean of 54 different algorithms. Five populations of yeasts (CALCOlow, CALCOhigh 
and CMFDAhigh, CMFDAmed, CMFDAlow) and 8 groups (a to h) of algorithms clustered. Cluster h that includes 
all size and most location algorithms allowed discrimination between CALCOhigh, CALCOlow and the 3 other 
populations. Cluster b distinguished CALCOlow from the 4 other populations based on some signal strength 
and texture algorithms. Cluster c highlighted CMFDAlow compared to the 4 other populations based on 
some shape and location algorithms.
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Figure 18: Morphological and fluorescence features of the CALCOhigh/CMFDAhigh 
H99 population in lungs of OF1 outbred mice.  
A) Multispectral imaging flow cytometer (ImageStreamX, Amnis) was used to picture each event of the 
CALCOhigh/CMFDAhigh population in 5 channels: bright field (BF, transmitted light), yellow (Cy3, capsule), 
green (CMFDA, stress response), blue (CALCO, multiplication), red (TOPRO, viability). Different patterns of 
morphology and CMFDA fluorescence were observed. B) The CALCOhigh/CMFDAhigh population of yeasts 
from lung homogenates was also observed using classical fluorescence microscopy. CMFDA fluorescence 
was observed surrounding the cell wall CMFDAsur (white dotted arrows in panel A), or within the cytoplasm 
of the yeast (CMFDAintra, white arrows in panel A). C) Based on the modulation algorithm (texture) and the 
area (size) of the yeasts, CMFDAintra and CMFDAsur were easily discriminated. The CMFDAsur yeasts were 
composed of regular Cn cells and ‘Drop Cn’ cells. Distribution of the CMFDAsur and CMFDAintra yeasts (D) 
and Drop and Reg Cn (E) in the 3 CALCO populations. (F) Proportion of Drop Cn in the 3 CMFDA popula-
tions.
!                                                                                                                                                
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Figure 19: Morphological features and metabolic activity of the ‘Drop Cn’ population 
in the lungs of OF1 outbred mice. 
Yeasts from lung homogenates were observed using interferential contrast microscopy. A) A subpopulation 
of yeasts was observed with a typical morphology: small size (5.80µm ± 0.80, n=12), thick cell wall, and one 
well-defined round refringent vesicle. B) Nucleus morphology (DAPI, Blue), RNA content (SYTO85, Orange) 
and mitochondrial activity (Mitotracker, Orange) were assessed in yeasts previously stained with CMFDA 
(green). ‘Drop Cn’ were devoid of nucleus (regular shape and regular DAPI fluorescence), RNA and mito-
chondrial activity in comparison with regular yeasts (Reg Cn). C) Lipid membrane layers (MDY64, green) 
was assessed in unstained yeasts. ‘Drop Cn’ harbored a complete retraction of the cytoplasm around the 
central refringent vesicle. 
A
B C
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Figure 20: Diversity of phenotype of 2 clinical isolates compared to H99 
Contrasted distribution of CALCO/CMFDA (A higher panel, B) and sizes (A lower panel, C) for AD1-07a 
and AD1-83a compared to H99 assessed using ImagestreamX. (D-F) Contrasted proportion of Drop Cn 
considering specific populations for AD1-07a and AD1-83a compared to H99. (F) Similar proportion of dead 
yeasts as assessed by TOPRO fluorescence cells for clinical isolates and H99. (G) Contrasted proportion of 
CMFDAsur and CMFDAintra populations for AD1-07a and AD1-83a compared to H99 with a lower proportion 
of Drop Cn being CMFDAsur in AD1-83a.
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Figure 21: Growth curves analysis of different CMFDA populations after sorting.  
The yeasts recovered from macrophage lysis (MP) after 24 hours of interaction (A, B) or lung homogenates 
(MO) from infected outbred mice (C, D) were stained and then sorted (FACSAria II, BD) and optically con-
trolled (E). Stationary yeasts stained at the same time (sSTAT, red) were used as control. For each popula-
tion, yeasts (104/ml) were allowed to grow in YPDps (dashed lines) or YPDps+10% fetal calf serum (+FCS, 
solid lines) in 96 well-plate at 30°C with agitation (800 rpm). The optical density (OD) at 600 nm was record-
ed over time. A) Four CMFDA populations (CMFDA/CALCO dot plot) were studied: CMFDAhighCALCOhigh 
(yellow), CMFDAmedCALCOhigh (orange) CMFDAlowCALCOhigh (blue) and CMFDAhighCALCOlow (green). B) The 
exponential growth phase of the CMFDAlow population (blue) was delayed compared to that of the 3 other 
populations and sSTAT. Onset of the exponential phase occurred earlier with addition of FCS. C) Three 
CMFDA populations (CMFDA/SSC dot plot) of yeasts recovered from pooled lungs homogenates were ana-
lyzed: CMFDAhigh (yellow), CMFDAmed (orange) CMFDAlow (blue). D) The CMFDAlow population (blue) failed to 
grow in YPD even after 48 hours of incubation. Addition of FCS restored growth capacities even though 
onset was delayed by ≥10hours compared to the other populations and sSTAT. In addition, growth of 
CMFDAhigh and CMFDAmed populations was delayed compared to sSTAT.
A B
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Figure 22: Heat map of genes expression analysis (n=37) for different CMFDA popu-
lations using real-time quantitative PCR. 
CMFDA populations of yeasts recovered from macrophages (MP) or murine lungs (MO) were studied. After 
lyophilization, yeasts were lysed and primer specific reverse transcription and quantitative PCR were per-
formed. The target selected (n=37) were genes involved in growth, stationary phase, resistance to oxidative 
stress, autophagy, adaptation to lung environment, and capsule and chitin formation. For each gene, the 
fold change compared to ACT1 and GAPDH genes was normalized between 0 and 1 (A). The genes for 
which amplification failed are depicted in grey. MO_CMFDAmed and MO_CMFDAhigh from mice clustered 
together apart from the other populations. All macrophage populations except MP_CMFDAlow clustered 
together. The pattern of expression for MP_CMFDAlow and MO_CMFDAlow was different from the other pop-
ulations and between them except for PCK1 and COX1 (red arrows). Four clusters of genes can be differen-
tiated with C1 specifically clusters genes involved in lung adaptation during infection [26] and C4 com-
posed of genes more expressed in the MP_CMFDAlow population (A, B).
A
B
!                                                                                                                                                
!
Addition of FCS restored growth for the MO_CMFDAlow population and markedly 
accelerated growth for all populations including sSTAT in MP. Of note, for CMFDAmed and 
CMFDAhigh, growth curves in MO but not in MP were delayed compared to sSTAT and 
close to each other (Figure 21B, 21D).

Gene expression analysis based on 37-selected genes was performed for the above 
populations using real-time quantitative PCR (Figure 22A-B). Hierarchical clustering of 
yeasts populations revealed that for both MP and MO conditions CMFDAmed and 
CMFDAhigh populations were close to each other. Overall, four groups were delineated: 
the MO_CMFDAhigh, the MP_CMFDAhigh population, and the CMFDAlow populations of MO 
and that of MP. Of note, the CMFDAhigh population clustered with sSTAT (data not shown). 
Hierarchical clustering of genes revealed 4 clusters with 2 clusters of particular interest, 
clusters 1 (C1) and 4 (C4) (Figure 22A-B). C1 was composed of genes known to be up-
regulated in lung during early infection [26]. C4 included genes that were more expressed 
in the MP_CMFDAlow population. Finally, PCK1 down-regulation and COX1 up-regulation 
were observed only in the MO_ and MP_CMFDAlow populations. 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Addition of FCS restored growth for the MO_CMFDAlow population and markedly 
accelerated growth for all populations including sSTAT in MP. Of note, for CMFDAmed and 
CMFDAhigh, growth curves in MO but not in MP were delayed compared to sSTAT and 
close to each other (Figure 21B, 21D).
Gene expression analysis based on 37-selected genes was performed for the above 
populations using real-time quantitative PCR (Figure 22). Hierarchical clustering of yeasts 
populations revealed that for both MP and MO conditions CMFDAmed and CMFDAhigh 
populations were close to each other. Overall, four groups were delineated: the 
MO_CMFDAhigh, the MP_CMFDAhigh population, and the CMFDAlow populations of MO 
and that of MP. Of note, the CMFDAhigh population clustered with sSTAT (data not shown). 
Hierarchical clustering of genes revealed 4 clusters with 2 clusters of particular interest, 
clusters 1 (C1) and 4 (C4) (Figure 22A-B). C1 was composed of genes known to be up-
regulated in lung during early infection [26]. C4 included genes that were more expressed 
in the MP_CMFDAlow population. Finally, PCK1 down-regulation and COX1 up-regulation 
were observed only in the MO_ and MP_CMFDAlow populations.
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No. of yeasts x105 (mean±SDa) for analysis of
 
 
Growth curves Gene expression
MP MO MP MO
CMFDAlow 5.8 ± 0.1 0.7 ± 0.2 8 ± 1.6 1.1 ± 0.6
CMFDAmed 12.8 ± 2.5 2.5 ± 1.5 17.4 ± 2.1 4.6 ± 0.3
CMFDAhigh 38.8 ± 3.9 0.6  ± 0.2 26.5 ± 0.7 0.9  ± 0.1
CMFDAhighCALCOlow 27.0 ± 7.1 ND 27.5 ± 3.5 ND
Table 3: Distribution of the various CMFDA populations studied after 24 hours of 
macrophage interaction (MP) and in lungs of infected outbred mice (MO) 
ND: not done; a Two independent experiments for MP and for MO (21 and 42 pooled lungs re-
covered 7 days after inoculation)
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Rapid overview of the literature on C. neoformans and cryptococcosis clearly shows the 
complexity and the diversity of the host/yeast interplay. This includes on the host side 
multiplicity of organisms potentially exposed to C. neoformans [29,175], diversity in 
human susceptibility to infection [109] and clinical presentation [11] and well-established 
differences in the interaction between yeasts and immune cells [5,153,176]. On the fungal 
side, the diversity is also noticeable at several levels:  genome [177], genotypes [38], 
capsule structure [178,179], production of other virulence factors [40,41], interaction with 
hosts cells [22,23,151], virulence in mice [22,23], microevolution during infection 
[5,30,180]. 
!
1. How new standardized assays and new tools are needed to study 
C. neoformans adaptation !
To study the dynamics of the C. neoformans adaptation to host and to analyze 
microbiological phenotypes according to clinical parameters, we implemented new tools 
and standardized assays that bypass pitfalls of classical methodologies. A careful reading 
of common methods in immunology as well as eukaryote cellular biology lead us to hijack 
tools that have rarely or never been used with fungi.

The quantification of C. neoformans multiplication was based on calcofluor staining and 
its ability to be sparsely transmitted to daughter cells during budding. Indeed, bud 
formation in basidiomycetous yeasts is enteroblastic [181]. The inner layer of the parental 
multilamellar cell wall is in direct continuation with the outer layer of the bud [182]. Given 
that chitin (~9% of the cell wall) is distributed throughout the cell wall [183], the 
calcofluor-labeled chitin of the mother cell wall could contribute to the fluorescence of the 
daughter cells. This assay represents a promising alternative to current studies dealing 
with microscopic or colony forming units enumeration and have potential wide 
applications. It could become, as CFSE assay in immunology [184], an easy/reliable test 
to study dynamics of fungal cell proliferation. Such assay could be easily used for drug 
discovery [185] or to study the basics of cellular biology of Cryptococcus infection 
(phagocytosis, trafficking, antimicrobial properties) using either C. neoformans mutant 
libraries or RNAi library for macrophage modifications [47,186].

Glutathione is a non-enzymatic defense system against oxidative stress. CMFDA has 
previously been used in mammalian and fungi to quantify glutathione [161,162,187] or as 
a long-term cell tracker since it leaves the yeasts viable [86]. Our experiments in C. 
neoformans demonstrated that yeasts responded to various stresses by increasing 
glutathione. In case of protracted or violent stress exposition (hydrogen peroxide), the 
pool of glutathione is emptied in C. neoformans as also shown in Saccharomyces 
cerevisiae [188,189]. The combined use of CALCO staining allowed us to compare stress 
response in mother and daughter cells.

To detect and exclude dead cells from the analysis, we used Topro-3 iodide that follows 
the same principle than propidium iodide staining only yeasts with altered cellular 
membrane [190]. Since propidium iodide fluorescence can be detected in the FITC 
channel, already used for CMFDA detection, it was necessary to use a marker that emits 
fluorescence in other wavelength and Topro-3 iodide emitting in the APC channel was the 
ideal one. 
The use of quantitative flow cytometry (Macsquant® analyzer, Miltenyi) allowed absolute 
quantification of large samples when dealing with yeasts/macrophages interactions (more 
than 106 yeasts and 105 macrophages) and accurate intra vs. extracellular, and mother vs. 
daughter yeast cells’ discriminations. A combination of a panel of dyes (4 fluorescence 
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channels of detection) and the three assays described above (multiplication, stress 
response and viability) allowed quantification in a unique step.

Flow cytometry is a powerful tool especially when dealing with planktonic mammalian 
cells. However, for yeasts that can harbor various morphological features and be 
associated with tissue debris when recovered from in vivo experiments, fluorescence 
quantification alone is insufficient to obtain accurate data. Consequently, to detect 
artifacts and analyze morphological features of C. neoformans cells obtained from mice, 
we used imaging multispectral flow cytometry (ImagestreamX®, Amnis corp.) that put 
together pictures and fluorescence intensity data for about 10,000 events. We were able 
to detect artifacts of the CMFDA staining as the location of the staining was high and 
extracellular for some yeasts cells (Figure 18), allowing us to re-classified these cells as 
CMFDAlow population since intracellular staining was low. In addition, numerous 
algorithms generated from pictures in the bright field channel provided deeper analysis of 
the morphology and allowed delineation of homogenous yeast populations. Based on the 
13 size algorithms, the biggest cells corresponding to titan cells clustered together and 
were almost exclusively composed of mother cells in the lungs (Figure 20D) confirming 
data obtained from in vitro culture [67]. Furthermore, the CMFDAlow population also 
clustered separately based on 3 algorithms (angle intensity, elongatedness, symmetry2). 
This specific population would not have been detected by classical tools, highlighting the 
power of multispectral flow cytometry.

However, we were confronted with the low number of yeasts cells recovered from in vivo 
experiments. This forced us to develop tools using relative quantitative real-time PCR 
adapted for reduced size samples (Table 3). RNA extraction from low number of cells 
especially yeasts cells is tricky. Previous study reporting on relative quantitative PCR 
without RNA extraction [191] lead us to implement a direct one step real-time PCR. Lysis 
steps with buffer inhibiting PCR inhibitors provides stabilization of mRNA for primer 
specific reverse transcription and subsequent quantitative amplification based on the 
detection of specific fluorescent probes. Since a library of 90 octamer fluorescent probes 
was commercially available, we designed quantification assays for 54 genes that were 
validated for 37 genes. However, amplification sometimes failed for the samples 
containing the lowest quantity of yeasts (Mo_CMFDAlow or Mo CMFDAhigh samples). 
Another explanation could be a profound down-regulation of these genes.
!
2. How to study the complexity C. neoformans/macrophage 
interaction from a fungal point of view. !
Cryptococcus neoformans interacts closely with various host cells (murine and human 
macrophages or amoeba [2,5,141]) with the hypothesis that interaction with unicellular 
predators in nature shaped C. neoformans behavior in metazoan organisms [1]. 

With the aim to compare the phenotype of clinical isolates upon macrophage interaction, 
we chose J774 cells for the assays. Although results from this model could not be 
generalized to other systems and in particular to what happens in vivo in humans, it has 
the advantage of reproducibility, standardization, and wide use in the literature and allows 
the use of a murine IgG monoclonal antibody as opsonin.

The fate of C. neoformans in contact with host cells is dependent of multiple and yet 
partially unknown factors. The first one is phagocytosis. Phagocytosis of C. neoformans is 
known to be inhibited by capsule components so that an opsonin (complement or 
immunoglobulin) is required to study this process. Unexpectedly, we found that E1 (anti-
capsular monoclonal antibody) binding level inversely correlated with the phagocytic 
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index (Figure 9). This suggests that, in addition to Fc and complement-receptors [192], 
other receptors involved in innate immunity, such as mannose receptors, CD14, TLR-4 
[193], or factors modulating phagocytosis, such as the secreted protein App1p [63], the 
pleiotropic transcription factor Gat201p or the Gat201-bound gene Gat204p [66], play a 
role in the phagocytosis process. 

After phagocytosis, C. neoformans intracellular persistence and proliferation are key steps 
in the pathogenesis process. We found a relationship between the intracellular 
proliferation of clinical isolates and intra-macrophagic expression of COX1, IPC1, VAD1, 
APP1, and PLB1. Specific mitochondrial morphology and metabolism were associated 
with C. gattii isolates recovered from the Vancouver Island outbreak [22]. This validates 
the FACS-YMI assays as an innovative mean to study virulence factors and potentially 
decipher the mechanisms by which C. neoformans escape or survive phagocytosis. 
Dissociation between early (IPH2) and late (IPH48) intracellular proliferation indexes was 
observed for some clinical isolates as well as for lac1∆ mutant. We also found that a 
variable proportion of the intracellular yeasts were still CALCOhigh after 48 hours of 
incubation, suggesting that they could either be viable mother cells that did not lose their 
fluorescence or mother cells in a low-replicative stage. There is no clue to favor one 
hypothesis since observation of replication of mother cells during its life course is 
technically difficult. The use of microfluidic device that block the mother cell and eliminate 
daughter yeasts cells as soon as they are generated though a flow could be an option but 
this kind of tool is rare. Nevertheless, these data suggest that adaptation inside 
macrophage occurs. 

Using dynamic imaging of C. neoformans/macrophage interaction, we observed 
macrophage division after yeast uptake, as previously described [85]. This suggests that 
C. neoformans is not toxic for the phagocytic cell and reinforce some steps of 
cryptococcosis’ pathophysiology such as the phagocytic cell as a potential niche for C. 
neoformans latency and as a vehicle (Trojan horse) for dissemination [7] and bypass of the 
immune response. Interestingly, we did not observed vomocytosis during our 
experiments. The lack of macrophage activation with interferon gamma or LPS could be 
an explanation.
!
3. How diverse are C. neoformans clinical isolates 
Using a large collection of clinical isolates, we uncovered highly variable phenotypes of C. 
neoformans/macrophage interaction without correlation with genotypes in contrast with 
what was demonstrated for the clonal hypervirulent VGII C. gattii isolates [22]. This could 
be explained by differences in the pathophysiology of infections due to C. gattii and C. 
neoformans, the first being more frequently responsible for primary infection rather than 
reactivation in contrast with C. neoformans-related diseases [15,147]. As a consequence, 
virulence of these two pathogenic fungi in humans could be different in terms of host 
adaptation and immunological escape mechanisms. One may also wonder if the 
phenotypic intra-species diversity reported for eukaryotes, as opposed to prokaryotes, 
could be explained by their complex genome, and potential recombination events during 
mating. This is especially true for C. neoformans, knowing its complex sexual 
reproduction [28]. Some strains may have “ready made” virulence [1]  (high IPH2, high 
IPH48) whereas, for others (low IPH2, high IPH48), a longer period of metabolic 
adaptation to hypoxia or starvation inside macrophages could be needed to multiply and 
express virulence factors as described in vivo [26]. Overall, these various phenotypes 
could reflect different patterns of pathogenicity. Given the complex biological processes 
that lead to survival or multiplication inside the phagolysosome, other studies are needed 
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to decipher the precise mechanisms and molecular events involved. At the end, one can 
wonder if the use of one strain (a reference strain) is sufficient to draw general conclusion 
on the global knowledge of C. neoformans phenotype in various contexts. Variations of 
30-, 50-, and 16-fold were observed among clinical isolates in terms of phagocytic, 2-
hours or 48-hours proliferation indexes respectively (Figure 8). These variations must 
impact C. neoformans interactions with hosts in vivo, especially when innate immunity is 
known to be important during infection. These variations have also been observed in 6 
isolates of the same reference strain (NIH52D) originating from 6 research laboratory, for 
which a local evolution through iterative in vitro experiments or inappropriate storage 
conditions were suspected [194]. To circumvent partially this issue, some authors 
systematically screened different reference strains. 
!
4. How the diversity of C. neoformans clinical isolates impacts 
clinical outcome !
Up to now, C. neoformans/host cells interactions have mostly been studied using 
reference or mutant strains. Few reports discuss the variability inferred by clinical isolates 
for C. neoformans [151], other fungal species [22,195], or parasites [196-199], and none 
analyzed correlation with clinical outcome. Since yeast/macrophages interactions are 
involved in pathogenesis, we assessed whether the phenotypes determined in vitro were 
associated with specific outcome in humans.  We found that isolates harboring low PI and 
low IPH2 were significantly associated with non-sterilization of CSF at week 2, whereas 
those harboring high PI and high IPH2 were associated with death at month 3. Our results 
suggest that fungal determinants are involved, as are host factors (genetic background, 
type of immunosuppression) in the outcome of cryptococcal meningoencephalitis. These 
results highlight the monocyte/macrophage lineage as a major key player in the 
pathophysiology of the infection in humans, as already suggested by studies on blood-
brain barrier crossing and dissemination in mice [7,200,201]. Additional experiments are 
needed to assess the relevance of these data in different clinical settings, such as 
infections with other serotypes, mixed infections, and extrameningeal cryptococcosis. 
Unpublished data from another group corroborate our hypothesis since they found that 
highly phagocytosed strains are associated with high CSF burden which is known to be 
associated with poor outcome [202]. In addition, a recent report found a relationship 
between capsular size in CSF at baseline ex vivo (and not in vitro) and slower rate of 
fungal clearance and high intracranial pressure in patients [203]. Both parameters are 
known to be associated with a poor outcome, reinforcing the hypothesis that fungal 
determinant and/or fungal adaptation to hosts are involved in clinical features of the 
disease [204,205].

While many studies established that host susceptibility to infection is crucial and that 
virulence factors of the pathogens can be differentially expressed as a function of 
environmental conditions (medium, intracellular vs. free yeasts, etc.), we demonstrate 
that, in the same experimental conditions, clinical isolates of C. neoformans behaved 
differently, a diversity that could participate in the variable outcome of 
meningoencephalitis in humans. As a consequence, our assays developed to quantify 
phagocytic and proliferation indexes can be used as a prognostic tool that could in the 
future be used to intensify antifungal therapy if the isolate harbor a phenotype associated 
with mortality (high PI, high IPH2).

To go further and to understand which are the fungal determinants that play a role in 
some specific intrinsic phenotypes of the clinical isolates, we are currently performing (i) 
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whole genome sequencing, and (ii) transcriptome analysis using RNAseq methodology at 
baseline and upon 2 hours uptake by macrophages. We already identified several factors 
associated with resistance to phagocytosis by analyzing gene expression of 13 clinical 
isolates at baseline. Since KO mutants impact drastically the metabolism of the yeast by 
abolishing the expression of one protein but also down stream and/or upstream 
pathways, analyzing precisely well-selected clinical isolates could be a way to understand 
phenotypes more physiologically. However, this kind of study will generate complex data 
and could be therefore difficult to interpret.
!
5. How heterogeneous is C. neoformans population upon 
interaction with host !
Fungal adaptation to specific host environments has been demonstrated [26,27,206,207] 
without focus on specific subpopulations of yeasts, except for the titan cells that have 
been recently reported in the lungs of infected mice [67,68]. We hypothesized that 
metabolically-different subpopulations of yeasts coexist in organs upon infection with the 
ambition to identify a population of dormant cells thanks to the combination of 
complementary tools (discussed above).

An intriguing observation was the extracellular (CMFDAsur) and not cytoplasmic 
(CMFDAintra) pattern associated with yeasts harboring specific morphology (Drop Cn) in 
lungs. The peripheral extracellular staining could be related to either excretion of 
glutathione or diffusion of host’s glutathione during infection or processing of the 
samples. Various stainings for metabolic activity (stress response, mitochondria, RNA 
content) and cell architecture (nucleus, plasma membrane, cell wall, capsule) as well as 
dynamic imaging strongly suggested that Drop Cn cells are mostly mother cells but dead 
cells. The negative TOPRO staining can be explained by the loss of nucleic acids 
evidenced by DAPI and SYTO 85 stainings. It is noteworthy that yeasts cells looking like 
Drop Cn are brought out in many publications without discussion of their viability. It is 
noticeable that these dead yeasts are not completely cleared. Their intact cell wall and 
capsule could prevent clearance and inhibit phagocytosis.

Analysis of multiplication and stress response revealed the coexistence of several 
subpopulations of yeasts that evolved over time in the host. The proportion of the various 
populations also varied upon hosts (OF1 vs. BALB/c), tissues (lungs vs. brain), models (in 
vitro vs. in vivo) and C. neoformans strains (H99 vs. well-characterized clinical isolates). 
This clearly underlines that results on global C. neoformans adaptation to various 
environments should be interpreted with caution. Sorting of the various populations of 
yeasts may thus help understanding C. neoformans biology in the host. 
!
6. Biological evidence of dormancy 
The commonly accepted pathophysiology is that most cases of C. neoformans infection 
result from the reactivation of dormant yeasts cells without precise knowledge on their 
site of residence. We focused here on the lungs of infected mice because it was the only 
body site in which well-delineated populations with sufficient number of cells for specific 
analysis were observed. Zaragoza and Nielsen evoked the possible role of titan cells in 
dormancy [208]. However, our experiments showed that CMFDA phenotype is not 
correlated to the size of the cell suggesting that titan cells may not be dormant cells 
knowing also from previous reports that they are prone to spontaneous multiplication 
upon standard culture conditions (Sabouraud agar plates) [67]. 

Dormancy has already been described in various environments in a wide range of 
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organisms including bacteria [209] (Bacillus spp., Clostridium difficile, Chlamydia spp., 
Vibrio spp, Pseudomonas spp.), mycobacteria (Mycobacterium tuberculosis [210-212]), 
Apicomplexan parasites (in particular Plasmodium spp. [213]) and yeasts (Saccharomyces 
cerevisiae [214], Schizosaccharomyces pombe [215]), and potentially spores of 
filamentous fungi (Aspergillus fumigatus [216] and Neurospora crassa [217]). In C. 
neoformans, dormancy has only been identified epidemiologically [16] and evoked for 
basidiospores [218]. From a biological point of view, we assumed that dormant cells 
would be metabolically poorly active. The population that met this criterion was the 
CMFDAlow that included less than 20% of Drop Cn. The delayed or nil growth of 
CMFDAlow population in YPD was partially rescued after addition of fetal calf serum, a 
phenotype described for dormant cells of various origins (mammalian fibroblasts, 
mammalian cancer cells, stem cells, bacteria and S. cerevisiae) [219]. This suggested that 
CMFDAlow population could be composed predominantly of dormant cells.

The limited number of cells after sorting (Table 3) led us implement transcriptional gene 
analysis based on adaptation of single-PCR assays. The finding that a cluster of genes 
(C1, Figure 26), known to be overexpressed during lung infection [26], was up-regulated 
only in yeasts recovered from lungs (MO_CMFDAmed, MO_CMFDAhigh), was a means to 
validate the technical and biological approach.

The major difference between the CMFDAlow population and the others whatever the 
condition, was the modulated expression of PCK1 (decrease) and COX1 (increase) genes. 

The phosphoenolpyruvate carboxykinase 1 (Pck1) protein plays a major role in 
gluconeogenesis, known to impact yeasts survival and to be required for virulence [158]. 
It is dependent on the DEAD-box Rna helicase, Vad1. PCK1 in S. cerevisiae is shown to 
be up-regulated under elevated CO2 concentration during carbon limitation [220]. The 
decreased PCK1 expression in CMFDAlow populations suggests active glycolysis 
metabolism in contrast with CMFDAmed and CMFDAhigh populations where glyoxylate 
cycle and gluconeogenesis is activated (Figure 22, Cluster1). As reported recently, 
glucose utilization is critical for virulence and persistence of the yeasts in CSF of rabbits 
[221].

COX1 (encoding the mitochondrial cytochrome c oxidase subunit 1) is up-regulated 
during stress response induced by high temperature (39°C) [174] and differentially 
expressed in well-characterized clinical isolates in correlation with intra-macrophagic 
proliferation [23]. COX1 and respiratory proteins in general are up-regulated in response 
to hypoxia as opposed to what is observed in S. cerevisiae, S. pombe, C. albicans where 
they are down regulated [222,223].  In C. neoformans, mutations in various mitochondrial 
genes affect respiration rate, response to oxidative stresses and ability to survive in low 
oxygen conditions [224,225], and this, independently of glutathione activity. In C. gattii, 
enhanced mitochondrial activity and modifications of mitochondrial morphology was 
found to be related to increased proliferation rate and virulence [22]. 

The increased ATG9 and VPS13 expressions (MP_CMFDAlow) give additional evidence 
that CMFDAlow population could use autophagy to survive.	  
Taken together, these data suggest that the CMFDAlow population is dormant in response 
to hypoxic conditions that could take place in some niches of the lung (for example in 
granuloma) during infection [222]. Further experiments are needed to find a way to 
generate dormant C. neoformans cells to go deeper in the biology of dormancy in this 
organism. 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1. Primer table 1 
 Primers used to study gene expression of virulence factors after macrophage 
interaction with 9 clinical isolates and H99 reference strain !
!!
2. Primer table 2 
Primers used to study gene expression of 37 fungal genes involved in starvation, 
resistance to oxidative stress, stationary phase metabolism, autophagy, and chitin 
and capsule formation !
Name Sequence (5’ to 3’)
Size 
(bp)
Concentra
tion (μM)
MgCl2
CX49a TGAGAAGGACCCTGCCAACA 197 0.5 -
CX50a ACTCCGGCTTGTAGGCATCAA
vfsa-IPC1F1 TTGCCACACCTGGGAATC 87 0.5 -
vfsa-IPC1R1 TTTGCATCGGTGCCGAG
vfsa-VAD1F2 ATTATCCCTACCCTTAACCGAAT 91 0.5 -
vfsa-VAD1R2 ATGTTTGAAGTGCGAGTTCT
vfsa-APP1F1 CTGTGCCAACTGTGTTGAAAT 122 0.3 2mM
vfsa-APP1R1 TGCTGAGTAACGCAGTTTGGA
vfsa-URE1F1 CGATTCTGGCACAAATGCTAT 105 0.3 -
vfsa-URE1R1 AGAGCCCTGTCAATGACT
vfsa-LAC1F1 AGAAGGGAAGGAAGGTGATG 101 0.3 -
vfsa-LAC1R1 TATACCTCACAACCGCCAAT
vfsa-PLB1F1 CTGCTTTGAGGACTACCTATGAGCGA 119 0.5 -
vfsa-PLB1R1 CCTTGAGTTGTAACCACCATTGACGAA
vfsa-COX1F1 CTGGTATGACACTACACAAGATGCCTC 92 0.5 -
vfsa-COX1R1 ACCAGCTAGAACTGGGATACATAGGA
Primer_ID Gene Primer_sequence Universal !
ProbeLibrary 
(Roche)
Tm
18_s_rRna_1 18S_rRNA
18S_rRNA_1591P agcgtgagtcaccagctcgc na 68
18S_rRNA_1510F ggcctgggtaatcttgtgaa 61
18S_rRNA_1636R gtacaaagggcagggacgta 63
CNAG_00396 TPK3
CNAG_00396_F484 actcaagctgcccttgaaac 27 59
CNAG_00396_R543 ggaagttgggaccctagca 60
CNAG_00483 ACT1
CNAG_00483_F715 ctcatggagcgtggttacct 29 60
CNAG_00483_R774 aatgtctcgaacgatttctcg 59
CNAG_00570 BCY1
CNAG_00570_F906 gctgatgcacaatgctcct 38 59
CNAG_00570_R973 ccagggcccataaagtacaa 59
CNAG_00797 ACS2
CNAG_00797_F1455 cgatgtagagggtgttctcgt 79 59
CNAG_00797_R1518 cctgtagacagtcctggcaat 59
CNAG_01232 PMC1
CNAG_01232_F437 gatggtcaattgggacttgg 32 60
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CNAG_01232_R496 tcttcatggagtagccgtctg 60
CNAG_01445 ATG9
CNAG_01445_F114 ttcgttgcatgttcaagacg 35 60
CNAG_01445_R173 gtcctcaatgcatcgctttc 60
CNAG_01480 RPL12A
CNAG_01480_F412 tctgttggttgcactgttgac 79 59
CNAG_01480_R497 tactcgtcgggaacgacaat 60
CNAG_01496 PPT1
CNAG_01496_F122 ttccttcgcctgttttgagt 54 59
CNAG_01496_R184 gctctccatcagatcccaac 59
CNAG_01722 VPS13
CNAG_01722_F7450 aacgcaatcgacatgatgg 83 60
CNAG_01722_R7509 agcggtggaaggcacttt 60
CNAG_02503 GPX2
CNAG_02503_F488 aatgtgttggccgatatggt 31 60
CNAG_02503_R547 tctcgatttcttccttgagctt 59
CNAG_03143 HSP12
CNAG_03143_F138 ccaatcccagaagtcttacacc 126 59
CNAG_03143_R209 gactcctggttgtcgttcttg 59
CNAG_03202 CYR1
CNAG_03202_F1679 tgccaggtaggattgtcctc 13 60
CNAG_03202_R1738 ccgtcccagtaaatggtgtc 60
CNAG_04217 PCK1
CNAG_04217_F1277 gcaggtatgccaagatgctc 58 60
CNAG_04217_R1339 tgatcaaccaacaattgactctg 60
CNAG_04448 RPL19A
CNAG_04448_F399 gaacaagcgtgtcttgatgg 7 59
CNAG_04448_R458 ttggttcggagcttctcg 60
CNAG_04485 FAA1
CNAG_04485_F1559 aagcctttaccgaggatggt 9 59
CNAG_04485_R1619 ccgtccttattccattgtcc 59
CNAG_04621 GSY1
CNAG_04621_F488 aagccggtttagccatcc 4 60
CNAG_04621_R550 tggtgaagattgtggtgacg 60
CNAG_05303 ICL1
CNAG_05303_F990 acagtcgatcggcacctc 78 59
CNAG_05303_R1051 ctggcagaccgaacgatt 59
CNAG_05653 MLS1
CNAG_05653_F649 gaagctcgactttggaacga 29 60
CNAG_05653_R708 ctgctgaacacccaaatgac 59
CNAG_06114 VPS21
CNAG_06114_F351 tgttatcgctctcgtcggta 58 59
CNAG_06114_R425 tcggaagatgaagatgcaga 59
CNAG_06174 GCN2
CNAG_06174_F2803 gtgcggcaacccagtatc 65 60
CNAG_06174_R2862 ttcgtttgatttgtggtttgg 60
CNAG_06642_R4725 acggaggtaagcgaagatga 59
CNAG_06668 AIM38
CNAG_06668_F255 gtctggtgtcggtcagaagg 34 60
CNAG_06668_R326 tgtgtcattttcccccactt 60
CNAG_06699 GAPDH
CNAG_06699_F858 cgttggcactaccgaatctt 64 60
CNAG_06699_R924 gacaaagttggcattaagagca 59
 84
!                                                                                                                                                
!!!!!!!!
CNAG_06892 ATG3
CNAG_06892_F564 ggcagtgaggattgtgcat 30 59
CNAG_06892_R634 tcacttgaaggaggttctttcc 59
CNAG_06908 SNZ2
CNAG_06908_F689 ctgcgccttatcatttgttg 41 59
CNAG_06908_R749 aaggaaacgacgggcaat 60
CNAG_06917 PRX1
CNAG_06917_F471 cgaaatcttgcgtgtcattg 78 60
CNAG_06917_R530 ggggtggtgatacggtgtt 60
CNAG_07531 SNO1
CNAG_07531_F505 acgccaacaaagacagacg 4 59
CNAG_07531_R575 ggcggtgaagggatgtact 59
CNAG_07561 GND1
CNAG_07561_F457 ccccacatcaaggacatctt 44 59
CNAG_07561_R519 gtcacagcagggctcacc 60
CNAG_00746 CAS35
CNAG_00746_F274 aggcttggatttacgctgaa 69 59
CNAG_00746_R333 accaaatttgctgcccttt 59
CNAG_01164 GFA1
CNAG_01164_F241 gcgaaggagaaggttgacat 30 59
CNAG_01164_R301 gggtatgtgccatcgaggt 60
CNAG_01019 SOD1
CNAG_01019_P262 atccagacgaacagctgcg na 63
CNAG_01019_F242 acgttggtgacctcggtaat 59
CNAG_01019_R306 gtcggaaaagtcgagctgag 60
CNAG_01283 CAP5
CNAG_01283_F55 cccgcgtctacatctcatct 39 60
CNAG_01283_R114 agtgtgggtcgaaggaatgt 59
CNAG_05581 CHS4
CNAG_05581_F1778 tgcttgtctcgtcatctcgt 10 59
CNAG_05581_R1838 tgccttctagtctcgccaac 60
CNAG_05799 CDA2
CNAG_05799_F1320 cacttcttccagcgggtct 83 60
CNAG_05799_R1383 agcggcaagagcaatgag 60
CNAG_06016 CAP6
CNAG_06016_F1657 gataccgttcgttgggtcaa 78 60
CNAG_06016_R1716 tgtagtctcagaagcggaagg 59
CNAG_07937 CAS1
CNAG_07937_F327 gtttgttggggactcgacag 59 60
CNAG_07937_R394 tagatgccttgccgacctt 60
CNAG_09009 COX1
CNAG_09009_F91 gctttctctgttcttatccgactt 50 59
CNAG_09009_R155 tggtcaccgtttagaaattgg 59
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Dynamics of Cryptococcus neoformans-Macrophage Interactions Reveal
that Fungal Background Influences Outcome during Cryptococcal
Meningoencephalitis in Humans
Alexandre Alanio,a,b,c Marie Desnos-Ollivier,a,b and Françoise Dromera,b
Institut Pasteur, Molecular Mycology Unit, Paris, Francea; CNRS URA3012, Institut Pasteur, Paris Franceb; and Service de Maladies Infectieuses et Tropicales, Hôpital Necker-
Enfants Malades, Paris, Francec
ABSTRACT Cryptococcosis is a multifaceted fungal infection with variable clinical presentation and outcome. As in many infec-
tious diseases, this variability is commonly assigned to host factors. To investigate whether the diversity of Cryptococcus neofor-
mans clinical (ClinCn) isolates influences the interaction with host cells and the clinical outcome, we developed and validated
new quantitative assays using flow cytometry and J774 macrophages. The phenotype of ClinCn-macrophage interactions was
determined for 54 ClinCn isolates recovered from cerebrospinal fluids (CSF) from 54 unrelated patients, based on phagocytic
index (PI) and 2-h and 48-h intracellular proliferation indexes (IPH2 and IPH48, respectively). Their phenotypes were highly
variable. Isolates harboring low PI/low IPH2 and high PI/high IPH2 values were associated with nonsterilization of CSF at week
2 and death at month 3, respectively. A subset of 9 ClinCn isolates with different phenotypes exhibited variable virulence in mice
and displayed intramacrophagic expression levels of the LAC1, APP1, VAD1, IPC1, PLB1, and COX1 genes that were highly vari-
able among the isolates and correlated with IPH48. Variation in the expression of virulence factors is thus shown here to depend
on not only experimental conditions but also fungal background. These results suggest that, in addition to host factors, the pa-
tient’s outcome can be related to fungal determinants. Deciphering the molecular events involved in C. neoformans fate inside
host cells is crucial for our understanding of cryptococcosis pathogenesis.
IMPORTANCE Cryptococcus neoformans is a life-threatening human fungal pathogen that is responsible for an estimated 1 million
cases of meningitis/year, predominantly in HIV-infected patients. The diversity of infecting isolates is well established, as is the
importance of the host factors. Interaction with macrophages is a major step in cryptococcosis pathogenesis. How the diversity
of clinical isolates influences macrophages’ interactions and impacts cryptococcosis outcome in humans remains to be eluci-
dated. Using new assays, we uncovered how yeast-macrophage interactions were highly variable among clinical isolates and
found an association between specific behaviors and cryptococcosis outcome. In addition, gene expression of some virulence
factors and intracellular proliferation were correlated. While many studies have established that virulence factors can be differ-
entially expressed as a function of experimental conditions, our study demonstrates that, under the same experimental condi-
tions, clinical isolates behaved differently, a diversity that could participate in the variable outcome of infection in humans.
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With 1million cases per year and 700,000 annual deaths, cryp-tococcosis is one of the most frequent invasive fungal infec-
tions worldwide (1). It occurs mostly in patients with immune
defects, especially those with AIDS, but also non-HIV immuno-
compromised patients (e.g., patients with sarcoidosis, solid organ
transplant patients, and patients under steroid or other immuno-
suppressive therapy) (2). Cryptococcosis is a multifaceted pathol-
ogy in terms of clinical presentation and outcome, withmeningo-
encephalitis being the most frequent and severe presentation.
Despite undergoing 3 months of adequate antifungal treatment,
15 to 20% patients will die from cryptococcosis (3). This infection
is due to the haploid yeasts Cryptococcus neoformans, including
varieties grubii (serotype A) and neoformans (serotype D), and
Cryptococcus gattii. C. neoformans propagates by budding and is
also capable of sexual multiplication and same-sex mating, which
contributes to the high diversity of the overall population, even if
asexual expansion is the predominant feature (4). The isolates
responsible for infections are serotype A or D, haploid or diploid,
and mating type alpha (MAT!) or a (5). Single (one strain) or
mixed (mixture of isolates belonging to various serotypes, mating
types, genotypes, and/or ploidies) infections are possible, as evi-
denced in unpurified clinical cultures (6). Overall, haploidC. neo-
formans serotype A MAT! isolates represent the most prevalent
clinical isolates worldwide (5).
C. neoformans is a facultative intracellular pathogen (7–9). In-
teraction ofC. neoformanswith host cells can lead to phagocytosis,
with occasional escape to the extracellular space (vomocytosis),
and possible transfer of yeast cells between phagocytic cells (10).
RESEARCH ARTICLE
July/August 2011 Volume 2 Issue 4 e00158-11 ® mbio.asm.org 1
 
m
bio.asm
.org
 on August 10, 2011 - Published by 
m
bio.asm
.org
Downloaded from
 
!                                                                                                                                                
 883
C. neoformans is capable of replication within the phagolysosome,
sometimes associated with host cell lysis (10). These interactions
are thought to be involved in different steps of pathogenesis, such
as dormancy (11), dissemination (8, 12), and blood-brain barrier
crossing (8). Ma and colleagues reported that C. gattii genotype
VGII (responsible for the Vancouver Island outbreak) was associ-
ated with increased intramacrophagic yeast proliferation and vir-
ulence in mice compared to other genotypes (13). For C. neofor-
mans, the influence of genotypic/phenotypic diversity on
pathogenesis and clinical outcome has not yet been established.
Our hypothesis is that the clinical outcome of cryptococcal
meningoencephalitis in humans is related to fungal determinants
and not only to the individual’s immune status and/or genetic
susceptibility to infection. We took advantage of a large prospec-
tive multicenter study on cryptococcosis (3) that collected clinical
information and isolates to test this hypothesis. We thus devel-
oped a standardized model of yeast-macrophage (murine cell line
J774) interactions to study C. neoformans clinical (ClinCn) iso-
lates and assessed the correlation between the in vitro parameters
characterizing the isolates and the outcome of infection in the
corresponding patients.
RESULTS
New flow cytometry assays are implemented to assess the dy-
namics of C. neoformans-macrophage interactions. To estimate
whether the interaction betweenClinCn isolates and host cells was
variable, we developed original quantitative flow cytometry assays
using the J774 murine macrophage cell line. Calcofluor (Calco) is
a basic fluorescent dye used to stain fungal cell wall. Preliminary
studies usingCalco staining revealed that fluorescence is transmit-
ted frommother to daughter cells duringmultiplication (Fig. 1A).
Immediately after staining, mean fluorescence intensity (MFI)
was high for all cells. After 3 h of culture, an emerging population
with a decreasedMFI was detected, while budding cells harboring
decreased fluorescence were seen by fluorescence microscopy.
This suggested that Calco-labeled chitin was transferred from
TABLE 1 Characteristics of the 54 patients corresponding to the 54
clinical isolates of Cryptococcus neoformans studied
Parameter n (%)
Male/female ratio 4.4:1
Born in Africa 12/54 (22.2)
HIV infected 45/54 (83.3)
Non-HIV infected 9/54 (16.7)
Abnormal neurology 24/54 (44.4)
Abnormal brain imaging 18/51 (35.3)
Disseminated infection 35/54 (64.8)
Capsular polysaccharide titer of!512 in CSF 27/49 (55.1)
Nonsterilization of CSF at wk 2 24/45 (53.3)
Death at mo 3 11/53 (20.8)
FIG 1 Decrease in fluorescence in calcofluor-labeled C. neoformans (reference strain H99) during multiplication. (A) C. neoformansmultiplication in vitrowas
evaluated after staining of yeast cells with calcofluor prior to incubation at 30°C in liquid YPD for up to 24 h. Aliquots of the culture were harvested at various
times (starting at 0 h of incubation [H0]), and fluorescence was assessed in parallel by microscopic observation and flow cytometry. Decreasing numbers of
brightly fluorescent cells were observed from H3 to H24 after incubation, and flow cytometry revealed the appearance of cells of intermediate fluorescence
intensity (daughter cells; medium blue) compared to the negative control (light blue) and the initial population (mother cells, dark blue). (B to D) Visualization
of H99 multiplication inside macrophages assessed by dynamic imaging. Yeast cells were stained with calcofluor prior to incubation with the J774 cell line at a
2.5:1 ratio in the presence of E1 anticapsular polysaccharide monoclonal antibody (E1 MAb) (106 yeast cells/1 !g E1 MAb). Dynamic imaging using the Nikon
Biostation was performed starting after 1 h of coincubation (images obtained at 16 h 45min are shown). (B) DAPI fluorescence filter. (C) Transmitted light. (D)
Decreased fluorescence of daughter cells assessed after image treatment using ImageJ software (merging panels B and C and inverting the look-up table [LUT].
Mother C. neoformans cells appear black, whereas daughter cells look medium to light gray. Original magnification,"40.
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mother to daughter cells during budding. During protracted in-
cubation, several populations with decreased MFI progressively
appeared, while the high-Calco-fluorescent initial population
progressively disappeared over 24 h. This phenomenon was con-
firmed using dynamic imaging of yeast cells proliferating inside
J774 cells (Fig. 1B to 1D; see Fig. S1 and Movie S1 in the supple-
mental material). Of note, macrophages containing yeast cells
were capable of mitosis (Fig. S1B and S1C) and subsequent fusion
(Fig. S1D and S1E) (14).
Based on these observations, we decided to assess the dynamics
of yeast-macrophage interactions (YMI) by flow cytometry assays
(using a fluorescence-activated cell sorter) using the MacsQuant
analyzer (FACS-YMI, Fig. 2). Preliminary experiments using the
C. neoformans reference strain H99 helped us define optimal op-
sonin quantity (monoclonal antibody [MAb] E1) and a yeast/
macrophage ratio in comparison with microscopic results (see
Fig. S2A in the supplemental material). In the phagocytosis assay,
three distinct populations were observed on the Calco-fluorescein
isothiocyanate (FITC) dot plot: the intracellular C. neoformans
population, which was high for Calco fluorescence and FITC neg-
ative (Calcohigh FITCneg); the extracellular C. neoformans popula-
tion, which was Calcohigh and FITC positive (Calcohigh FITCpos);
and cell debris, whichwasCalconeg FITCneg (Fig. 3A). This allowed
us to define a phagocytic index (PI) (103 !7 for H99). In the
proliferation assay, three distinct intracellularC. neoformans pop-
ulations (allophycocyanin-positive [APCpos] FITCneg gate) were
observed: the mother C. neoformans cell population, which was
Calcohigh, and two populations of daughter cells that were
Calcomedium and Calcolow (Fig. 3B), the cells with the lowest fluo-
rescence being the smallest cells (Fig. S2B). Intracellular prolifer-
ation indexes were then calculated based on the number of
Calcohigh, Calcomedium, and Calcolow populations after 2 h (IPH2)
and 48 h (IPH48) of incubation (1.0 !0.2 and 1.2 !0.2, respec-
tively, for H99).
Results obtained with H99 mutants validate the FACS-YMI
assays. To validate the assays, mutant strains derived from H99
and known for increased phagocytosis (app1" and lac1") and
decreased proliferation (vad1", vps34", ipc1", and lac1") were
screened in comparison to H99. The FACS-YMI assays allowed
discrimination between mutant strains based on PI, IPH2, and
IPH48 (P # 0.0001 each) (Fig. 4). For the mutants, the PIs were
categorized into two groups (similar to H99 [ranging from 0.8 to
1.2] for vps34", ipc1", and vad1" or higher [from 1.5 to 1.9] for
app1" and lac1"). Three categories were also delineated for IPH2
(very low [0.02 to 0.04] for vad1" and vps34", intermediate low
[0.35] for lac1", and low [0.7] for app1" and ipc1") and for
IPH48 (very low [0.02 to 0.2] for vps34" and vad1", low [0.8] for
lac1", and high [2.9 to 3.1] for app1" and ipc1").
Interactions of C. neoformans clinical isolates with J774
macrophages are highly diverse. Based on these validated FACS-
YMI assays, we then studied 54ClinCn isolates recovered from the
cerebrospinal fluid (CSF) of HIV-positive or -negative unrelated
patients (Table 1). An important diversity in terms of genotypes
(11multilocus sequence types) and baseline phenotype character-
istics (colony morphology, cell and capsule sizes, growth rate, E1
MAb binding level, chitin content, and urease and laccase activi-
ties) was observed (see Fig. S3 in the supplemental material). We
then established the diversity of the ClinCn-macrophage interac-
tions. A 30-fold variation in PI (Fig. 5A; Fig. S4 in the supplemen-
tal material), 50-fold variation in IPH2, and 16-fold variation in
IPH48 (Fig. 5A; Fig. S5 in the supplemental material) were found.
The ClinCn isolates exhibiting high (!0.5) PI and low (#1.0) E1
MAb binding level were mostly smooth (26/30 [86.7%]), com-
pared to those exhibiting low PI and high E1 binding, which were
mostly mucous (9/10 [90%]; P # 0.0001) (Fig. S6 in the supple-
mental material). There was no significant association between
genotypes and baseline phenotypes or phenotypes of ClinCn-
macrophage interaction (Fig. S7 in the supplemental material).
FIG 2 Schematic representation of Cryptococcus neoformans (Cn) labeling steps for flow cytometry analysis of yeast-macrophage interaction (FACS-YMI).
Yeasts were first stained with calcofluor and then incubated with J774 cells at 37°C in the presence of E1 MAb (opsonin). After careful PBS washings, the
incubation was stopped after 2 h of incubation (phagocytosis assay) (A) or prolonged incubation up to 48 h in fresh medium (proliferation assay) (B). In both
assays, the remaining extracellular yeast cells were then stained with anti-IgG–FITC antibody and washed, and J774 cells were lysed using H2O. An additional
labeling step was performed in the proliferation assay with E1 MAb and anti-IgG–APC added to stain daughter yeast cells. Samples were analyzed using the
MacsQuant analyzer.
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ClinCn-macrophage interaction phenotypes are associated
with variable outcome of cryptococcal meningoencephalitis in
humans. Given the high variability of ClinCn-macrophage inter-
action phenotypes, we then wondered if these parameters (PI,
IPH2, and IPH48) correlated with outcome of infection in the
corresponding patients. Four categories of isolates were defined
according to PI (!0.5 and !0.5) and IPH2 ("1 and "1). Based
on univariate analysis, nonsterilization of CSF despite 2 weeks of
antifungal therapy was associated with a population of isolates
harboring decreased PI and IPH2 (Fig. 5B; Table 2). The propor-
tions of parameters previously (3) associatedwith nonsterilization
of CSF (gender, dissemination, or high CSF antigen titer) did not
significantly differ among the four categories of isolates. Death at
months 3 was significantly associated with a population of isolates
harboring high PI and IPH2 (Fig. 5B). Parameters previously (3)
associated with death at month 3 (abnormal neurology or brain
imaging) did not significantly differ among the four categories. In
the multivariate analysis, the risk of nonsterilization of the CSF at
week 2 was independently associated with low PI and IPH2 (odds
ratio [OR], 15.5; 95% confidence interval [95%CI], 1.3 to 184.4;P
# 0.030) and with HIV infection (OR, 25.2; 95% CI, 1.8 to 348.6;
P# 0.016) (Table 2).
Expressionof somevirulence factors correlateswithClinCn-
macrophage interaction phenotypes.Considering that in a stan-
dardized in vitro model, variations in ClinCn-macrophage inter-
action phenotypes were associated with different outcomes in
humans, we further explored known virulence factors in relation
to these phenotypes.We selected nineClinCn isolates (s9-ClinCn)
based on various combinations of their ClinCn-macrophage in-
teraction phenotypes (Fig. 6A), genotypes, and related patient
outcomes. All s9-ClinCn isolates were fertile (data not shown),
with variable virulence inmice, as shown bymedian survival rates
FIG 3 The FACS-YMI allowed assessment of the dynamics of yeast-macrophage interactions. (A) Determination of C. neoformans phagocytosis. Intracellular
C. neoformans cells (Calcohigh FITCneg) were easily discriminated from extracellular C. neoformans cells (Calcohigh FITCpos) and macrophage debris (Calconeg
FITCneg). (B) Determination of C. neoformans intracellular proliferation. After selection of the APCpos (excluding cell debris, upper left graphs) and FITCneg
populations (intracellular C. neoformans, lower left panels), different subsets of intracellular C. neoformans cells corresponding to mother (Calcohigh) and
daughter (Calcomedium and Calcolow) C. neoformans cells were observed (right panels). A decrease of mother cells in parallel to an increase in the daughter cell
population was observed between 2 h (H2) and 48 h (H48) of coincubation, asserting intracellular proliferation. (The number of events is reported above each
subset.)
FIG 4 Screening of well-characterizedmutant strains compared toH99 using
the FACS-YMI assay. Dot plots presenting the corresponding values for
phagocytosis (PI) and intramacrophagic proliferation at H2 (IPH2) and H48
(IPH48) for each mutant linked by a solid line (log10 scale). PIs were catego-
rized in two groups: similar to H99 (vps34$, ipc1$, and vad1$mutants) and
higher than H99 (app1$ and lac1$ mutants). Three categories were also de-
lineated for IPH2 (very low for vad1$ and vps34$, intermediate low for lac1$,
and low for app1$ and ipc1$), and for IPH48 (very low for vps34$ and vad1$,
low for lac1$, and high for app1$ and ipc1$).
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(expressed as a ratio for each s9-ClinCn isolate to H99) ranging
from 0.57 (AD2-82a) to 3.3 (AD1-07a) (Fig. 6B; P! 0.0001). The
2-h intracellular (iH2) and baseline (BsH2) relative expressions of
six virulence factors (LAC1, URE1, APP1, VAD1, IPC1, and PLB1
genes) (15–20) and one mitochondrial gene (COX1, coding for
cytochrome oxidase 1) (13, 21) were quantified with GAPDH
(coding for glyceraldehyde-3-phosphate dehydrogenase) as the
reference gene and H99 as the control. High BsH2 APP1 expres-
sion ("5-fold) was significantly associated with low PI (P #
0.028). IPH48 expression and iH2 expression were significantly
correlated for IPC1 (R2# 0.73, P# 0.003), APP1 (R2# 0.66, P#
0.008), COX1 (R2 # 0.66, P # 0.008), VAD1 (R2 # 0.65, P #
0.009) (Fig. 6C), andPLB1 (R2# 0.55,P# 0.021). Levels of PI and
iH2 expression of LAC1 (R2 # 0.59, P # 0.016) were also corre-
lated. Hierarchical clustering of iH2 and BsH2 expression levels
for the six genes together with PI, IPH2, and IPH48 generated four
clusters, confirming the previous correlations (see Fig. S8 in the
supplemental material). No correlation was found forURE1 gene
expression.
DISCUSSION
In order to assess the correlation between C. neoformans-
macrophage interactions and clinical parameters, we designed
new standardized assays. Since C. neoformans strains have been
shown to behave similarly in various host cells (murine and hu-
manmacrophages or amoeba) (22–24), we chose J774 cells for the
assays. The use of this cell line and flow cytometry allowed quan-
tification of large samples (more than 106 yeast cells and 105 mac-
rophages) and accurate discrimination of intra- versus extracellu-
lar and mother versus daughter yeast cells. The FACS-YMI assays
FIG 5 The 54 C. neoformans clinical isolates (ClinCn) (serotype A, MAT!, haploid) harbored variable interactions with macrophages (phagocytosis and
intracellular proliferation). (A) Compared to H99, the distribution of phagocytic (PI), 2-h proliferation (IPH2), and 48-h proliferation (IPH48) indexes showed
30-fold, 50-fold, and 16-fold variations, respectively (log10 scale). Each circle represents the mean of duplicates for a given ClinCn isolate obtained from two
independent experiments. Bars represent means $ standard deviations (SD) for the 54 ClinCn isolates. (B) Scatter plots presenting PI versus IPH2. Four
categories of isolates were defined according to PI (!0.5 and"0.5) and IPH2 (#1 and"1). The population of isolates harboring a PI of!0.5 and an IPH2 of
#1 was significantly associated with nonsterilization of CSF at week 2 (P# 0.03), and that harboring a PI of"0.5 and an IPH2 of"1 was significantly associated
with death at month 3 (P# 0.05).
TABLE 2 Patients’ outcomes are significantly associated with the phenotypes of interaction with J774 macrophages of the clinical isolates for which
the corresponding outcome was availablea
Outcomea Parameter
No. (%) of patients with: Univariate analysis Multivariate analysis
Failure (n# 24)
or death (n# 11)
Success (n# 21)
or survival (n# 42) OR 95% CI P OR 95% CI P
Yeast eradication
from CSF at wk 2
PI" 0.5, IPH2# 1 7 (36.8) 12 (63.2) Reference
PI! 0.5, IPH2" 1 4 (80.0) 1 (20.0) 6.86 0.63–74.19 0.113 5.79 0.53–63.37 0.150
PI" 0.5, IPH2" 1 6 (50.0) 6 (50.0) 1.71 0.40–7.43 0.471 3.48 0.61–19.78 0.159
PI< 0.5, IPH2< 1c 7 (77.8) 2 (22.2) 6.00 0.97–37.30 0.055 15.51 1.30–184.43 0.030
HIV positiveb 23 (95.8) 14 (66.7) 1.64 0.85–3.19 0.012 25.16 1.84–348.63 0.016
HIV negative 1 (4.2) 7 (33.3) 0.14 0.02–1.16
Death at mo 3 PI" 0.5, IPH2# 1 3 (13.0) 20 (87.0) Reference
PI! 0.5, IPH2" 1 1 (16.7) 5 (83.3) 1.34 0.11–15.70 0.819
PI> 0.5, IPH2> 1 6 (42.9) 8 (57.1) 5 1.00–25.02 0.050
PI! 0.5, IPH2# 1 1 (10.0) 9 (90.0) 0.74 0.07–8.13 0.806
a Patients’ outcomes are represented by nonsterilization of CSF at week 2 (i.e., failure or success at yeast eradication from CSF) and death at month 3 (i.e., death or survival).
b Only two variables were added to the model due to the small number of events recorded (n# 24).
c Parameters appearing in bold are statistically significant.
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were based on Calco staining and its ability to be sparsely trans-
mitted to daughter cells during budding. Indeed, bud formation
in basidiomycetous yeasts is enteroblastic (25). The inner layer of
the parental multilamellar cell wall is in direct continuation with
the outer layer of the bud (26). Given that chitin (~9% of the cell
wall) is distributed throughout the cell wall (27, 28), the Calco-
labeled chitin of the mother cell wall could contribute to the flu-
orescence of the daughter cells. The FACS-YMI assays represent a
promising alternative to current studies dealing with microscopic
or colony-forming unit enumeration and have potential wide ap-
plications. The FACS-YMI assay could become, like the carboxy-
fluorescein diacetate succinimidyl ester (CFSE) assay in immu-
nology (29), an easy and reliable test to study dynamics of fungal
cell proliferation.
Up to now, C. neoformans-host cell interactions have mostly
been studied using reference or mutant strains. Few reports dis-
cuss the variability ofC. neoformans clinical isolates (30), and only
a few dealt with parasites (31–34) and other fungal species (13,
35), and none have analyzed correlation with clinical outcome.
Using a large collection of ClinCn isolates, we uncovered highly
variable phenotypes of C. neoformans-macrophage interaction
without correlation with genotypes, in contrast with what was
demonstrated for the clonal hypervirulent VGII C. gattii isolates
(13). This could be explained by differences in the pathophysiol-
ogy of infections due to C. gattii andC. neoformans, the first being
more frequently responsible for primary infection rather than re-
activation, in contrast to C. neoformans-related diseases (36). As a
consequence, the virulence of these two pathogenic fungi in hu-
mans could be different in terms of host adaptation and immuno-
logical escape mechanisms. One may also wonder if the pheno-
typic intraspecies diversity reported for eukaryotes, as opposed to
prokaryotes, could be explained by their complex genomes and
potential recombination events during mating. This is especially
true for C. neoformans, known for its complex sexual reproduc-
tion (4).
Since yeast-macrophage interactions are involved in the patho-
genesis, we assessed whether the phenotypes determined in vitro
were associatedwith a specific outcome in humans.We found that
isolates harboring low PI and low IPH2 were significantly associ-
ated with nonsterilization of CSF at weeks 2, whereas those har-
boring highPI andhigh IPH2were associatedwith death atmonth
3. Our results suggest that fungal determinants are involved, as are
host factors (genetic background and type of immunosuppres-
sion) in the outcome of cryptococcal meningoencephalitis. These
results highlight themonocyte/macrophage lineage as amajor key
player in the pathophysiology of the infection in humans, as al-
ready suggested by studies on blood-brain barrier crossing and
dissemination in mice (8, 37, 38). Additional experiments are
needed to assess the relevance of these data in different clinical
settings, such as infections with other serotypes, mixed infections,
and extrameningeal cryptococcosis.
The fate of C. neoformans cells in contact with host cells is
dependent on multiple and yet partially unknown factors. The
first one is phagocytosis. Unexpectedly, E1 binding level inversely
correlated with PI. This suggests that, in addition to Fc! and com-
plement receptors (39), other receptors involved in innate immu-
nity, such as mannose receptors, CD14, and Toll-like receptor 4
(TLR-4) (40), or factors modulating phagocytosis, such as the
FIG 6 The in vivo behavior (virulence in mice) of the s9-ClinCn isolates is heterogeneous and the intracellular (J774 cells) expression levels of known virulence
factors correlate with the 48-h proliferation index. (A)Dot plots presenting the corresponding PI, IPH2, and IPH48 values for each of the s9-ClinCn isolates. The
values corresponding to a given isolate are linked by a solid line (log10 scale). (B)Outbredmalemice were intravenously inoculated with 105 yeast cells, and death
was recorded over 60 days. Compared toH99 (black circle, thick line), AD2-82a (open red circle, red dotted line) is more virulent (median survival ratio of 0.57),
whereas AD1-95a (blue triangle, blue dotted line) andAD1-7a (blue square, blue dotted line) are less virulent (median survival ratios of 2.1 and 3.3, respectively).
(C) Compared to H99, IPH48 of the s9-ClinCn isolates correlated with the intracellular expression of the IPC1, VAD1, APP1, and COX1 genes. Bars represent
means! standard deviations (SD) of duplicates from 2 independent experiments for each s9-ClinCn isolate. The linear regression curve is shown.
Alanio et al.
6 ® mbio.asm.org July/August 2011 Volume 2 Issue 4 e00158-11
 
m
bio.asm
.org
 on August 10, 2011 - Published by 
m
bio.asm
.org
Downloaded from
 
!                                                                                                                                                
 9388
secreted protein App1p (20), the pleiotropic transcription factor
Gat201p, or the Gat201-bound gene product Gat204p (41), play a
role in the phagocytosis process. After phagocytosis, C. neofor-
mans intracellular persistence and proliferation are key steps of
the pathogenesis process. We found a relationship between intra-
macrophagic COX1, as shown in C. gattii (13), but also IPC1,
VAD1, APP1, and PLB1 gene expression and ClinCn intracellular
proliferation. This validates the FACS-YMI assays as innovative
means to study virulence factors and potentially decipher the
mechanisms by which C. neoformans cells escape or survive
phagocytosis. Dissociation between early (IPH2) and late (IPH48)
intracellular proliferation indexes was observed for some ClinCn
isolates as well as for the lac1! mutant. We also found that a
variable proportion of the intracellular yeast cells were still Calco-
high after 48 h of incubation, suggesting that they could either be
dead or in a low replicative stage or dormancy. Altogether, this
suggests that adaptation inside macrophage occurs. Some strains
may have “ready-made” virulence (42) (high IPH2 and high
IPH48), whereas, for others (low IPH2 and high IPH48), a longer
period of metabolic adaptation to hypoxia or starvation inside
macrophages could be needed to express virulence factors as de-
scribed in vivo (43). Overall, these various phenotypes could re-
flect different patterns of pathogenicity. Given the complex bio-
logical processes that lead to survival or multiplication inside the
phagolysosome, other studies are needed to decipher the precise
mechanisms and molecular events involved.
In conclusion, whilemany studies established that host suscep-
tibility to infection is crucial and that virulence factors of the
pathogens can be differentially expressed as a function of environ-
mental conditions (medium, intracellular versus free yeasts, etc.),
our study demonstrates that, under the same experimental condi-
tions, clinical isolates of C. neoformans behaved differently, a di-
versity that could participate in the variable outcome ofmeningo-
encephalitis in humans.
MATERIALS AND METHODS
Cell line. The J774.16 cell line (hereafter J774) was purchased from the
American Type Culture Collection (ATCC) to study the interaction of C.
neoformans clinical isolates with macrophages. J774 is a murine
macrophage-like cell line derived from a reticulum sarcoma. Cells were
maintained at 37°C in the presence of 5% CO2 in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% heat-inactivated fetal
calf serum (FCS) and 1% penicillin–streptomycin (fresh medium) (all
from Invitrogen). Cells were used between 10 and 35 passages.
C. neoformans strains. A panel of 54 C. neoformans clinical isolates
was selected. All isolates were recovered from cerebrospinal fluids and
responsible for single infections (one isolate/one genotype/one infection),
as opposed to mixed infections (6). All isolates were collected during the
CryptoA/D prospective study (3). This study was approved and reported
to the French Ministry of Health (registration no. DGS970089). For each
isolate, the patient’s background, clinical presentation, outcome of infec-
tion, and various biological parameters were available (Table 1). Single
colonies (ClinCn) from each clinical isolate were frozen in 40% glycerol at
"80°C and used thereafter. All ClinCn isolates were characterized as hap-
loid, serotype A, MAT! using previously described methods (6). Before
each experiment, yeasts were first cultured on Sabouraud agar (SA) me-
dium and then subcultured in liquid yeast extract-peptone-glucose me-
dium (YPD) at 30°C at 150 rpm for 22 h (standard YPD culture). All
isolates were tested blind to the clinical parameters.
Mutant strains (all derived fromH99) with the genotypes lac1! (lack-
ing laccase 1 [Lac1p]) (44), vps34! (lacking the phosphatidylinositol
3-kinase [PI3-kinase] Vps34p) (45), vad1! (lacking the DEAD-box RNA
helicase Vad1p) (18) (kindly donated by P. Williamson, NIH, Bethesda,
MD), app1! (lacking the antiphagocytic protein App1p [20], which binds
the CR3 and CR2 receptors on phagocytic cells) (46), and ipc1! (in which
inositol-phosphoryl ceramide synthase, Ipc1p, is downregulated) (19)
(kindly donated by M. Del Poeta, Charleston, SC), were also used. Strain
H99 (serotype A, MAT!, haploid) (kindly donated by J. Heitman, Duke
University, NC) was used as the reference strain in all experiments.
Reagents and C. neoformans labeling. Calcofluor white dye (Calco)
(fluorescent brightener 28; Sigma) specifically stains chitin contained in
the cell wall of some eukaryote microorganisms and was used to label C.
neoformans. Yeast cells were collected from standard YPD culture, washed
twice, and resuspended in phosphate-buffered saline (PBS) (Invitrogen)
at 5 # 106 to 2 # 107/ml. The cells were then incubated with Calco at
10 "g/ml in PBS for 10 min in the dark at room temperature and then
washed twice in PBS. In preliminary experiments, we checked that the in
vitro growth curves of strains were similar (identical slopes) for Calco-
stained and unstainedC. neoformans strains, except for the lac1!mutant,
for which growth decreased after Calco staining (data not shown). To
assess the evolution of Calco fluorescence during multiplication, Calco-
stained C. neoformans cells (106/ml) cultured in standard YPD were ana-
lyzed using fluorescence microscopy (Zeiss Axioscope A1 with a 4=,6-
diamidino-2-phenylindole [DAPI] filter) and flow cytometry at various
incubation times. E1, a murine IgG1 monoclonal anticapsular polysac-
charide antibody (E1 MAb) was used as an opsonin (47). Fluorescein
isothiocyanate-labeled horse anti-mouse IgG (anti-IgG–FITC) (Vector
Laboratories) and allophycocyanin-labeled goat anti-mouse IgG (anti-
IgG–APC) (BD Pharmingen) were used at 1:100 for a 20-min incubation.
Baseline genotypes and phenotypes characterization of the ClinCn
isolates. The genotype of each ClinCn isolate was determined bymultilo-
cus sequence typing (MLST) of seven loci, as previously described (48).
The morphological aspect (smooth or mucous) was assessed after 72 h of
culture on SA at 30°C. Growth curves were determined in 96-well plates
starting at 106/ml without agitation in liquid YPD at 30°C (triplicate
wells). The optical density at 600 nm (OD600) was recorded up to 140 h of
incubation (LabsystemsMultiskan). The regression line (y$ ax% b) was
determined, and the results were expressed as the ratio between the slopes
(“a” value) for the ClinCn isolates compared to that for H99. Cell and
capsule sizes were determined after standard YPD culture. Cell suspen-
sions were made at 106/ml in PBS. An aliquot was observed in India ink
suspension, using an Axioscanmicroscope (Carl Zeiss, Germany) and the
AxioCam ICc1 camera (Carl Zeiss, Germany). Cell size, delineated by the
cell wall, and capsulated cell size, delineated by the white exclusion zone
around the cells, were measured for 10 cells randomly selected from each
ClinCn isolate and H99 using the Zeiss AxioVision software (Carl Zeiss,
Germany). Results were expressed as the average size ratio for ClinCn
versus H99 cells. The binding of E1MAb to the capsule surface was deter-
mined. Yeast cells were cultured on SA for 24 h at 30°C for each ClinCn
isolate, washed in PBS, and suspended at a concentration equivalent to an
OD600 of 0.1. Then, 300 "l of the suspension was centrifuged and pellets
were resuspended in 100 "l of PBS containing E1 MAb (0.5 "g/ml) and
FITC-labeled anti-IgG for 20min in the dark at room temperature. Then,
400 "l of PBS–1% paraformaldehyde (PFA) was added to fix cells before
cytometry analysis. The results were expressed as the ratio between the
geometric mean of the FITC fluorescence intensity for the ClinCn isolates
and H99. The chitin content was determined after standard YPD culture
and standard calcofluor staining by quantification of the geometric mean
of the calcofluor fluorescence intensity for the ClinCn isolates and H99
using flow cytometry (see below).
To study the variability of the s9-ClinCn, urease and laccase activities
were quantified using urea agar base medium (49) and asparagine agar
containing 1 mM L-3,4-dihydroxyphenylalanine (L-Dopa) (50). Urease
and laccase activities of 105 to 107 C. neoformans cells after 24 h of incu-
bation at 37°C and 72 h of culture at 30°C, respectively, were quantified by
measuring the diameter of the pink halo (urease), and the RGB content of
colonies (laccase), using ImageJ software. The mating assay used
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Murashige and Skoog medium (51), and fertility was assessed after 7 days
of incubation at room temperature in the dark with KN99a (serotype A,
mating type a), KN99! (serotype A, mating type !), and JEC20 (serotype
D, mating type a).
Interaction with macrophages. J774 cell suspensions (105 in fresh
medium per well of a 24-well culture plate) were incubated at 37°C in 5%
CO2 for 48 h. The day of the experiment, E1 MAb (250 "l) and Calco-
stained C. neoformans suspension (250 "l), both in fresh medium at the
desired concentrations, were added to the J774 cell monolayer and incu-
bated at 37°C and 5%CO2 for 2 h (phagocytosis assay,C. neoformans/J774
ratio, 5:1). Nonadherent extracellular yeast cells were then removed by
PBS washings, and incubation was stopped to assess phagocytosis or ex-
tended to determine intracellular proliferation. Phagocytosis was deter-
mined after staining residual extracellular yeasts using anti-IgG–FITC,
additional PBS washings, and macrophage lysis with distilled water
(Fig. 2A). The samples were then centrifuged, resuspended in 1% para-
formaldehyde in PBS (PFA-PBS), vortexed, and sonicated for 3 min be-
fore analysis.
To assess intracellular proliferation of ClinCn using flow cytometry
(proliferation assay, C. neoformans/J774 ratio, 2.5:1), the incubation was
protracted in freshmedium for 48 h. Residual extracellular yeast cells were
stained by addition of E1 MAb (0.5 "g/ml) and anti-IgG–FITC and
washed in PBS, and J774 cells were lysed by water (Fig. 2B). In order to
differentiate potentially unstainedC. neoformans cells from cell debris, an
additional step was done using E1MAb and APC–anti-IgG. All yeast cells
were APCpos, while only extracellular yeast cells were APCpos FITCpos.
Intracellular proliferation was determined for each ClinCn isolate at
the end of the phagocytosis step (H2) and at 48 h (H48). Phagocytosis and
proliferation were analyzed in two independent experiments.
Flow cytometry analysis of yeast-macrophage interaction (FACS-
YMI). Flow cytometry analyses were performed using MacsQuant ana-
lyzer and MacsQuantify software 2.0 (Milteniy BioTeC) to provide abso-
lute quantification. Samples were analyzed using FlowJo 8.7 software
(Tree Star, Inc.). Aggregates were excluded by gating relevant events in the
forward scatter/side scatter (FSC/SSC) contour plot. Three parameters
were calculated: (i) the phagocytic index (PI) as the number of events in
the Calcohigh FITCneg gate at H2, (ii) intracellular proliferation at H2
(IPH2) as the ratio between daughter cells (Calcolow! Calcomedium) and
mother cells (Calcohigh) at H2, and (iii) intracellular proliferation at H48
(IPH48) as the ratio between daughter cells (Calcolow! Calcomedium) at
H48 and mother cells (Calcohigh) at H2.
Results were expressed as the ratio of the given parameter for the
ClinCn/mutant strains compared to theH99 parameter determined in the
same run. We assessed that results obtained during the two independent
experiments were reproducible for PI, IPH2, and IPH48 (P" 0.0001 for
each parameter), and means of replicates were then used for subsequent
analyses.
Dynamic imaging. The evolution of fluorescence intensity from
mother to daughter intracellular yeasts was assessed by dynamic imaging
(Nikon Biostation). J774 cells were cultured and incubated with Calco-
stained C. neoformans cells (2.5:1) in dishes (Hi-Q4 35-mm diameter;
Nikon) at 37°C and 5% CO2. Series of images were taken by phase-
contrast and fluorescencemicroscopy (DAPI filter) every 5min for 24 h at
#40 magnification. Merging and inverting the look-up table (LUT) were
done using ImageJ software (http://rsb.info.nih.gov/ij/). The movie was
generated from the 289 modified pictures using iMovie software v8.0.6
(Apple, Inc.).
Virulence in mice. Outbred OF1 male mice (ages 6 to 8 weeks)
(Charles Rivers Laboratories) were housed 7 per cage in our animal facil-
ities and received food and water ad libitum. The inoculum was prepared
in sterile saline from standard YPD culture. The C. neoformans cell sus-
pension (105/mouse) was inoculated intravenously into 7 mice. Survival
was recorded once daily until day 60 after inoculation. Animals about to
die (unable to reach their food) were systematically euthanized by CO2
inhalation. Animal studies were approved by the Institut Pasteur Animal
Care Committee (03/144).
Real-time PCR.RNA extraction was performed on the s9-ClinCn iso-
lates and H99 cells coincubated with J774 cells (intracellular condition
[iH2]) or in fresh medium (baseline condition [BsH2]) for 2 h at 37°C in
5%CO2. For iH2, J774 cells were washed twice with PBS, scraped, lysed in
2ml 0.05% SDS–ice-cold water, and vortexed, and the pellet was collected
after 3min of centrifugation at 2,000 relative centrifugal force (RCF). RTL
lysis buffer (500 "l; Qiagen) and 1:100 #-mercaptoethanol (Sigma) were
added to the C. neoformans pellets. The suspensions were transferred to
Ceramique Magna Lyser green bead tubes (Roche Diagnostics), homog-
enized three times with the Magna Lyser instrument (30 s at 7,000 rpm),
and centrifuged (3min at 10,000RCF). RNA extractionwas performed on
350"l supernatant using the RNeasy minikit (Qiagen). RNAs were quan-
tified and qualified using theNanodrop spectrometer (ThermoFisher Sci-
entific, Inc.).
cDNA was generated from Turbo DNase (Ambion)-treated RNA us-
ing the Transcriptor first-strand cDNA synthesis kit (Roche Diagnostics).
Quantitative reverse transcription-PCR (RT-PCR) using 10 "l of Light-
Cycler 480 SYBR green I master, 2 "l of cDNA, and specific primers (see
Table S1 in the supplemental material) in a LightCycler 480 (Roche Diag-
nostics) consisted of a denaturation step at 95°C, 45 cycles of amplifica-
tion (95°C for 5 s, 60°C for 5 s, and 72°C for 5 s). Each cDNAwas analyzed
in duplicate andnormalizedwith the correspondingGAPDH gene expres-
sion (52) and was variable in different experimental conditions. Fold
changes for each s9-ClinCn isolate (iH2 and BsH2 conditions) were as-
sessed compared to H99 under the same conditions, according to Pfaffl
(53). Two independent RNA extractions for each conditionwere analyzed
blindly, and an internal calibrator consisting of an iH2 cDNA of H99 was
used in each RT-PCR run as recommended (54).
Statistical analysis.Graph and Pearson’s index (R2) calculation, exact
Fisher’s test, and one-way analysis of variance (ANOVA) were performed
using Prism 4.0 (GraphPad Software). Stata 10.0 software (Stata Corpo-
ration) was used to compare the ClinCn-macrophage interaction pheno-
types with clinical outcome for the corresponding patients. For the mul-
tivariate analysis, logistic regression was used to determine factors
independently associated with nonsterilization of CSF at week 2 (45 pa-
tients with available information). Only two variables were entered in the
model because of the limited number of events (n $ 24). Odds ratios
(ORs) and their 95% confidence intervals (95% CIs) were determined.
Schematic representation of fold changes was performed using the
open-source genomic analysis software MeV v4.6.1 (The TM4 Develop-
ment Group) obtained from http://mev.tm4.org (55). Complete linkage
clustering and Pearson’s correlation were chosen to perform hierarchical
clustering. The principal component analysis (PCA)was performed based
on three interaction parameters (PI, IPH2, and IPH48) and fivemycolog-
ical parameters (cell and capsule size, E1 binding, growth, and chitin con-
tent) using MeV v4.6.1 (Manhattan distance, mean centering mode, and
10 neighbors for KNN imputation). Variables were compared using the
Student t test. P values of$0.05 were considered significant.
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Dynamic Virulence: Real-Time Assessment of Intracellular
Pathogenesis Links Cryptococcus neoformans Phenotype with Clinical
Outcome
Michael K. Mansour,a Jatin M. Vyas,a and Stuart M. Levitzb
Department of Medicine, Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA,a and Department of Medicine, Division of
Infectious Diseases and Immunology, University of Massachusetts Medical Center, Worcester, Massachusetts, USAb
ABSTRACT While a myriad of studies have examined host factors that predispose persons to infection with the opportunistic fun-
gal pathogen Cryptococcus neoformans, comparatively little has been done to examine how virulence factor differences among
cryptococcal isolates may impact outcome. In the recent report by Alanio et al. (A. Alanio, M. Desnos-Ollivier, and F. Dromer,
mBio 2:e00158-11, 2011), novel flow cytometry-based techniques were employed to demonstrate an association between the phe-
notype of C. neoformans-macrophage interactions, as measured by phagocytosis and intracellular replication, and patient out-
comes, as determined by positive cultures on therapy and survival. These experiments establish that the prognosis of patients
with cryptococcosis is influenced by the phenotypic properties of the infecting fungal isolate.
Cryptococcus neoformans is an encapsulated opportunistic yeastwhich is responsible for approximately 1 million infections
and over 600,000 deaths per year worldwide (1). The patient pop-
ulations most affected are those with adaptive immunity dysfunc-
tion, specifically T-cell defects. Individuals suffering fromAIDSor
lymphoma or recipients of chronic immunosuppressive medica-
tion are at highest risk for developing cryptococcal infection (2).
C. neoformans is ubiquitous, but a higher rate of infection is ob-
served in sub-Saharan countries, which suggests that either there
are host factors that result in a more susceptible phenotype or
there are differences in the virulence of the fungal strains found in
these niches. More recently, hypervirulent strains of the closely
related speciesCryptococcus gattii have caused epidemic infections
in predominantly immunocompetent individuals (3).
C. neoformans can exist as a haploid or diploid organism and
divides using either an asexual budding cycle or a sexual stage with
conidial forms.Cryptococcus has a complete and intact life cycle in
the environment but has clearly found a niche as a mammalian
pathogen. The ability of C. neoformans to survive in the human
phagocyte may have evolved through the interactions of the fun-
gal cells with free-living amoebae (4).
Exposure toC. neoformans is thought to typically occur follow-
ing inhalation of airborne organisms. Once the organisms are in
the lungs, professional phagocyte populations (e.g., dendritic
cells, macrophages, and polymorphonuclear leukocytes) clear the
majority of the organism burden and potently influence the na-
ture and outcome of adaptive immune responses. The strong as-
sociation of CD4! T-cell depletion or dysfunction with crypto-
coccosis is testimony to the particular importance of this immune
cell to cryptococcal host defenses. For these reasons, studies aimed
at understanding the interaction between professional antigen-
presenting cells such as macrophages and Cryptococcus will help
define the steps leading to lasting immunity and correlate clinical
outcome.
In a recent issue of mBio, Alanio et al. (5) show that the inter-
action of Cryptococcus with host innate immunity is more com-
plex than previously thought. Using a large panel ofC. neoformans
organisms isolated fromcerebrospinal fluid (CSF) of patientswith
cryptococcalmeningoencephalitis, clinical outcomewas shown to
rely not only on host immune factors but also on specific virulence
properties of the organism. To accomplish this task, Alanio et al.
(5) devised an ingenious flow cytometry-based standardizedmac-
rophage assay that allowed quantification of both C. neoformans
phagocytosis and intracellular replication.Using a reference strain
and a macrophage-like cell line, indices were then generated re-
flecting rates of phagocytosis and intracellular proliferation. Re-
markably, based on these two metrics, the authors were able to
segregate the cryptococcal isolates into distinct macrophage phe-
notypes that correlated with clinical and microbiological out-
comes (Fig. 1). Patients with isolates that had both a high phago-
cytic index and high intracellular proliferation experienced a
5-fold-increased risk of death. On the other hand, patients with
isolates exhibiting both a low phagocytic index and low intracel-
lular proliferation had a 15-fold-increased risk of having positive
CSF cultures after 2 weeks of antifungal therapy. Interestingly,
phenotypic characteristics that have been associated with viru-
lence in animal studies (including capsule size, growth rate, chitin
content, and urease and laccase activities) did not correlate with
clinical outcome.
It is important to remember that because all the isolates in the
study byAlanio et al. (5) came frompatientswhohad cryptococcal
meningitis, they possess some degree of virulence. Thus, rather
than looking at virulence in the traditional sense, the authors have
taken a fresh approach by looking at how the interaction ofC. neo-
formans with macrophages in vitro correlates with outcomes in
patients who are already infected and receiving antifungal drugs.
The results suggest that a dynamic interplay between host innate
cells and Cryptococcus continues well after phagocytosis. In sup-
port of this concept, Alanio et al. (5) also demonstrated thatCryp-
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tococcus changes its gene expression profile within the macro-
phage phagolysosome.
Similarly to other intracellular pathogens, C. neoformans un-
dergoes phenotypic and perhaps genotypic change as it adapts to
life within the cell. One implication of the work of Alanio et al. (5)
is that these intracellular changes have significant clinical ramifi-
cations. The receptor-ligand interactions leading to phagocytosis,
antifungal activity, and cytokine responses have been well charac-
terized (6). However, we are just beginning to understand the
subsequent intracellular events occurring in the phagolysosomal
compartment and the consequences of these events. It is clear that
this period is not quiescent, and evidence ismounting that there is
continued sampling of the pathogens by the innate immune cell.
Recent studies have shown that the toll-like receptors (TLR), such
as TLR 9, continue to engage the fungal phagolysosome well be-
yond the initial surface events leading to phagocytosis (7). Data
also suggest that the fungal surface evolves within the phagosomal
compartment, presenting new and distinct antigens. This fact was
highlighted in a study ofAspergillus fumigatus conidia and hyphae
where each morphotype was found to elicit a unique immune
response (8).
How can we frame these data? The study by Alanio et al. (5)
suggests that fungal pathogenesis is dependent not only on host
response but also on the dynamic adaptations by the pathogen.
Other studies have also supported fungus-specific intracellular
virulence factors. C. gattii isolated from the Vancouver Island
outbreak has enhanced intracellular survival and proliferation
in macrophages. In this example, microarray analysis iden-
tified the majority of the gene expression differences, as com-
pared to control, to be centered on mitochondrial genes, which
are thought to promote a better-fit state of survival in a
phagolysosome (9). Our ability to understand how fungi sense
and adapt to intracellular compartments will be important for
deciphering the nature of the host-pathogen interaction. In
order to answer these questions, new techniques will need to be
developed to assess the activities within the phagosomal com-
partments of professional phagocytes. The work by Alanio et al.
(5) is an excellent example of the ingenuity required to advance
the field of fungal pathogenesis. Moreover, the authors’ suc-
cessful ability to correlate the macrophage phenotype of clini-
cal isolates with patient outcomes has “to-the-bedside” impli-
cations. In the future, therapy for cryptococcosis may very well
be individualized based on the phenotypic and genotypic char-
acteristics of both the host and pathogen.
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Abstract !
Cryptococcosis is an opportunistic infection due to the ubiquitous yeast 
Cryptococcus neoformans. This pathogen is a facultative intracellular organism. 
Interaction with immune cells including monocytes/macrophages lineage and dendritic 
cells are of major importance in the natural history of the infection. In humans, the 
pathophysiology of the infection evolves in three steps (i) primoinfection in childhood, (ii) 
dormancy, demonstrated from epidemiological and genotypic data in the lab few years 
ago (Garcia-Hermoso et al. 1999), (iii) reactivation upon immunosuppression. In terms of 
disease, clinical presentation and outcome of cryptococcosis are known to be diverse 
among individuals even those sharing the same underlying diseases. 
!
To address the question of the impact of fungal diversity on the natural course of 
the infection at the macrophage-level  (standardized model of yeasts/J774 macrophages 
in vitro interaction), murine model-level (murine model of cryptococcosis in OF1 outbred 
mice) and human-level (CryptoA/D database), we studied (i) the diversity of C. 
neoformans/macrophages interactions using well characterized clinical isolates (ii) the 
correlation between in vitro phenotype of the isolate and clinical outcome in humans (iii) 
the diversity of adaptation to the host. We developed new assays and new tools using 
flow cytometry (quantitative flow cytometry, multispectral imaging flow cytometry, 
sorting), microscopy (dynamic imaging), gene expression analysis  (single-cell quantitative 
real time PCR) to overcome technical issues.
!
We found high variation in phagocytic, 2 hours-, 48hours-intracellular proliferation 
indexes among the 54 ClinCn compared to H99. No correlation with the genotype was 
observed. The lack of sterilization at week 2 despite active antifungal therapy was 
significantly associated with a lower phagocytic index, whereas treatment failure at month 
3 and death from cryptococcosis were significantly related to a higher 2 hours-
intracellular proliferation. Among 9 selected clinical isolates compared to H99, (i) the 
virulence in mice was significantly different, intracellular expression of some virulence 
factors correlated with (ii) intracellular proliferation and (iii) phagocytic indexes. With a 
focus on multiplication and stress response and considering the H99 reference strain, we 
observed the appearance of various populations of yeasts during mice and macrophage 
infections. After sorting yeasts populations, we observed that a specific one was less 
prone and dependent of serum to grow compared to the other populations. Gene 
expression analysis revealed that this population had specific metabolic characteristics 
that could reflect dormancy.
!
We found a high diversity of C. neoformans upon interaction with macrophages 
considering 54 clinical isolates in correlation with clinical outcome in humans, but also a 
considerable adaptation to host in our two models considering the reference strains H99. 
We observed also even more diversity of fungal adaptation to host when clinical isolates 
were considered. All together, these data suggest that cryptococcosis and fungal disease 
in general could be more complex diseases since diversity, plasticity and adaptation of 
the fungal organism to hosts is high and heterogeneous.
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